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Abstract
Mild hypothermia at 32-35oC (HT) has been shown to be neuroprotective for neurological
emergencies following severe head trauma, cardiac arrest and neonatal asphyxia.
However, HT has not been widely deployed in clinical settings because: firstly, cooling
the whole body below 33-34°C can induce severe complications; therefore, applying HT
selectively to the brain could minimize adverse effects by maintaining core body
temperature at normal level. Secondly, development of an effective and easy to
implement selective brain cooling (SBC) technique, which can quickly induce brain
hypothermia while avoiding complications from whole body cooling, remains a
challenge. In this thesis, we studied the feasibility and efficiency of selective brain
cooling (SBC) through nasopharyngeal cooling. To control the cooling and rewarming
rate and because core body temperature is different from brain temperature, we also
developed a non-invasive technique based on time-resolved near infrared spectroscopy
(TR-NIRS) to measure local brain temperature. In normal brain, cerebral blood flow
(CBF) and energy metabolism as reflected by the cerebral metabolic rate of oxygen
(CMRO2) is tightly coupled leading to an oxygen extraction efficiency (OEF) of around
~33%. A decoupling of the two as in ischemia signifies oxidative stress and would lead to
an increase in OEF beyond the normal value of ~33%. The final goal of this thesis is to
evaluate TR-NIRS methods for measurements of CBF and CMRO2 to monitor for
oxidative metabolism in the brain with and without HT treatment.
Chapter 2 presents investigations on the feasibility and efficiency of the
nasopharyngeal SBC by blowing room temperature or humidified cooled air into the
nostrils. Effective brain cooling at a median cooling rate of 5.6 ± 1.1°C/hour compared to
whole body cooling rate of 3.2 ± 0.7 was demonstrated with the nasopharyngeal cooling
method.
Chapter 3 describes TR-NIRS experiments performed to measure brain
temperature non-invasively based on the temperature-dependence of the water absorption
peaks at ~740 and 840nm. The TR-NIRS method was able to measure brain temperature
ii

with a mean difference of 0.5 ± 1.6°C (R2 = 0.66) between the TR-NIRS and thermometer
measurements.
Chapter 4 describes the TR-NIR technique developed to measure CBF and
CMRO2 in a normoxia animal model under different anesthetics at different brain
temperatures achieved by whole-body cooling. Both CBF and CMRO2 decreased with
decreasing brain temperature but the ratio CMRO2:CBF (OEF) remained unchanged
around the normal value of ~33%. These results demonstrate that TR-NIR can be used to
monitor the oxidative status of the brain in neurological emergencies and its response to
HT treatment.
In summary, this thesis has established a convenient method for selective brain
cooling without decreasing whole body temperature to levels when adverse effects could
be triggered. TR-NIRS methods are also developed for monitoring local brain
temperature to guide SBC treatment and for monitoring the oxidation status of the brain
as treatment progresses.

Keywords
Temperature, Hypothermia, Nasopharyngeal cooling, Respiratory cooling, TimeResolved Near-infrared Spectroscopy, Cerebral blood flow, Cerebral metabolic rate of
oxygen, oxygen extraction efficiency, Oxidative Status, Piglets
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Chapter 1
Introduction
1.1 Overview
The central nervous system (CNS) has a high metabolic rate and depends on a
continuous blood supply of oxygen and nutrients and clearance of metabolic endproducts. In the event of interruption of circulation, function quickly fails, and if
circulation is not restored in a short time, irreversible damage to neurons occurs. The
most common causes of energy crisis are a severe drop in cerebral perfusion or ischemia
from arterial occlusion due to vasospasm or increased in intracranial pressure from brain
edema/herniation and a reduction in the oxygen content of blood referred or cerebral
hypoxia. Cerebral hypoxia refers to a lack of oxygen in the brain, even though blood flow
and pressure may be normal. It can be caused by many conditions including neardrowning, strangling, carbon monoxide and other poisonous gas exposures, chocking,
compression of the trachea, cardiac arrest, diseases which have paralyzed the respiratory
muscles, and birth asphyxia.
Clinical studies have shown that mild (32-35oC) and moderate hypothermia
improves neurological outcome and reduces mortality for a variety of acute brain injuries
following severe head trauma, cardiac arrest, stroke and neonatal asphyxia. However,
cooling the whole body below 33-34°C can induce severe complications including
sclerema, skin erythema, renal failure, coagulopathy, pulmonary hypertension, and even
death. Such complications along with other ones offset the benefits accrued from the
neuroprotective effects of hypothermia. In response to the aforementioned complications,
selective brain cooling (SBC) methods have been proposed to alleviate the complications
associated with systemic hypothermia by selectively cooling the brain while maintaining
normal core body temperature. However, SBC requires a non-invasive method that can
measure local brain temperature, since core measurements may not reflect brain

2
temperature. Improved cooling and monitoring technologies are still necessary to take in
the full potential of this therapy.
The next section of this chapter will introduce neonatal hypoxic-ischemic
encephalopathy (HIE) and describe the pathophysiology of the brain injury arising from
and the clinical management of this condition. The chapter will then focus on discussing
therapeutic hypothermia as the most promising neuroprotectant against hypoxic-ischemic
(HI) brain injury. The chapter ends with an overview of current techniques to measure
brain temperature and a discussion of near-infrared spectroscopy (NIRS) and its
application for measuring tissue temperature and cerebral hemodynamics and
metabolism. Finally, the objective and scope of the thesis are described to introduce the
work performed for chapters 2 through 5.

1.2 Neonatal Hypoxia-Ischemia
Neonatal HI is still one of the most important causes of disability and death
throughout the world.1 Approximately four million babies die every year in the neonatal
period, and one quarter of these deaths are attributed to HI.2 HI has an overall incidence
of 3-5 in 1000 births, and accounts for a large proportion of admissions to neonatal
intensive care; 10-15% of cases will die in the neonatal unit. Of the survivors, 10-15%
will develop cerebral palsy and up to 40% will have other significant disabilities.3
Undoubtedly, this clinical event is increasingly becoming a burden not only for the
patients, but also for the families and communities that care for them. This problem is a
financial issue as much as it is a health complication. The lifelong projected costs for
cerebral palsy alone are estimated at $11.5 billion dollars in the United States.4
HI triggers a cascade of events characterized by a reduction in cerebral blood flow
(CBF) and oxygen delivery. This phase is referred to as primary energy failure which is
associated with the reduction in high energy phosphate reserve, loss of membrane ionic
homostasis, excitotoxicity, an increase in intracellular calcium and the inhibition of
protein synthesis. Primary energy failure is followed by cell death. Secondary energy
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failure, which occurs during reperfusion and reoxygenation several hours after the initial
event and lasts for days. Secondary energy failure initiates a cascade of biochemical
events, which involve nitric oxide syntheses activation, the production of cytotoxic freeradicals, inflammation, membrane dysfunction and apoptosis, among others. The time
interval between primary and secondary energy failure is thought to be a latent phase
where therapies to reduce brain damage can be applied. This time interval is referred to as
"therapeutic window".

1.3 Pathophysiology of HI
The principal mechanism underlying neurological damage resulting from HI is the
deprivation of oxygen supply, which causes a primary energy failure. This energy failure
forces the cells to generate oxygen independent energy via glycolysis through anaerobic
respiration, which causes lactate production to increase (acidic bi-product of glycolysis in
the absence of available oxygen) and creates an acidic environment for the cells in CNS.5
The deleterious effect of this primary energy failure impairs vascular autoregulation (i.e.
the inability of the cerebral vasculature to maintain adequate CBF during systemic
hypotension), and the low pH halts the activity of cellular enzymes.6 The sodium
potassium (Na+/K+) adenosine triphosphate (ATP) pump will then begin to fail, and will
cause an intracellular accumulation of sodium (Na+), chloride (Cl-) and calcium ions
(Ca2+).7 The intracellular accumulation of these ions will cause the neurons to depolarize
and release a large amount of excitatory amino acid including glutamate. Glutamatergic
actions are mediated by two major receptors: N-methyl-D-aspartate (NMDA) and αAmino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). These receptors when
activated open agonist-operated ion channels, which allow ions to cross the membrane.
Extracellular glutamate can magnify intracellular concentrations of Ca2+ by opening
NMDA-Ca2+ and AMPA- and kainate-Na+ channels. Other effects of increased
intracellular Ca2+ include the generation of free-radicals and nitric oxide (NO). As
reperfusion occurs, glutamate levels return to normal, however; the glutamate receptors
may remain active as an important cause of brain cell death.
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During the reperfusion period, free-radical damage will be initiated and the
reactive oxygen species (ROS) will combine with the nitric oxide synthase (NOS) from
glutamate receptor activation to form toxic oxidants.8 Furthermore, calcium ion
accumulation will activate a series of enzymes which lead to oxidative degradation of
lipids and proteins and DNA damage.9 These damaging pathways will initiate the
apoptotic and necrotic cascade which will cause neurons to die. The releasing of proinflammatory cytokines by resident immune cells of the CNS, and peripheral immune
cells extravasating to the area of injury will initiate the inflammatory response10, all of
which contribute to cerebral edema, subsequently leading to neuronal death. The
continuum of neuronal death extends from early which is typically necrotic to delayed
apoptotic cell death.11 Apoptosis occurs over days as a result of a less severe insult, thus
is a potential therapeutic target.

1.4 Clinical Management of HI
Many potential neuroprotective drugs that target specific pathways of HI brain
injury have been investigated. These therapies operate at different times after the HI
insults, depending on their mechanisms of action (Figure 1.1). The main goals of these
interventions are decreasing the formation of toxic free-radicals to reduce cerebral
damage, and inhibiting the excessive influx of calcium into neurons to minimize cerebral
oedema.12
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Figure 1.1: Neuroprotective therapies and their optimal moment of administration, according to
their mechanisms of action.
Figure adapted from Cerio et al.12

Some interventions that have been investigated in animal and/or human trials
include: anti-oxidant interventions that could reduce free-radical formation after the HI
event such as allupurinol, statins, N-acetylcysteine (NAC), melatonin, cannabinoids,
erythropoietin, deferoxamine and hypothermia.12 Apart from producing an antioxidant
effect, NAC, cannabinoids, melatonin and hypothermia can also modulate the
inflammatory responses. Furthermore, administration of magnesium sulfate (MgSO4) has
been shown to be neuroprotective. MgSO4 is an NMDA receptor antagonist, which
prevents excitotoxic calcium-induced injury through the inhibition of NMDA receptor.13
Moreover, MgSO4 may also have direct actions on mitochondrial activity, have
anticonvulsant properties and beneficial haemodynamic effects by increasing cerebral
blood flow.
Likewise, the nontoxic anesthetic gas Xenon (Xe) has been shown to be an
effective neuroprotectant in a variety of neuronal injury models. Xe is a potent NMDA
antagonist, and has additional mechanisms of action such as inhibition of other subtypes
of

glutamate

receptors,

reduction

of

neurotransmitter

release,

inhibition

of

Ca2+/calmodulin-dependent protein kinase II, and protection against excitotoxicity.14
Furthermore, Xe is an attractive adjunct to hypothermia due to its lack of chemical
reactivity and toxicity, ease of reversibility and rapid brain penetration. It has been shown
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that neuroprotection significantly increased from ~35% with HT alone to ~70% when HT
was combined with 50% inhaled Xe gas.15 The major disadvantage of this intervention is
that Xe is very expensive and its administration is rather complicated, since it requires
intubation and ventilation of the patient as well as a large volume of expensive Xe gas.
Recently, Dingley et al. have developed a relatively straightforward rebreathing closed
circuit system suitable for cost effective delivery of Xe to mechanically ventilated
neonates as a potential neuroprotectant after perinatal asphyxia.16
Erythropoietin (EPO) has also shown great promise as a neuroprotectant against
HI brain injury.17 It was found to play a variety of roles in the modulation of
inflammatory responses and has vasogenic effects.18 It may activate antioxidant enzymes,
decrease excitotoxic damage, induce anti-apoptotic and anti-inflammatory factors and
inhibit lipid peroxidation.19 Another neuroprotectant is iminobiotin which has been shown
to inhibit both nNOS and iNOS in experimental studies.20
During HI brain injury, neurons, glia and endothelial cells are damaged causing a
reduction of their functionality or death. Recent advances in regenerative medicine
suggest that stem cell transplantation may improve repair of the damaged brain.21 It has
been shown that HI induced brain damage can be treated with Mesenchymal stem cells,
easily recovered from bone marrow, placental tissue, and umbilical cord stroma without
ethical problems.
Compared to the treatments discussed above, hypothermia appears to be a more
reliable intervention available at the moment for reducing the risk of death or disability
with brain injury22, as discussed in detail in the following section.

1.4.1 Therapeutic Hypothermia
Hypothermia can be classified as mild (32-35°C), moderate (28-32°C), severe
(20-28°C) and profound at less than 20°C. Clinical studies indicate that the temperature
range associated with better outcomes appears to be 33-35°C.23 Systemic adverse effects
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of hypothermia in general appear to be relative to the degree of cooling, occurring at core
temperatures < 34°C.24 The current practice of hypothermia intervention in HI is to
maintain a cerebral temperature of approximately 33-34°C for about 48-72 h22,
commencing as soon as possible after resuscitation.

a)

Neuroprotective Mechanism
Hypothermia is thought to interfere with different damaging cascades, being

protective both by itself and in prolonging the window for effective application of other
neuroprotective strategies such as anti-oxidant, anti-apoptotic, or anti-inflammatory drug
treatments.
Research has elucidated two distinct therapeutic windows for clinical use of
hypothermia. In the early intra-ischemia window, hypothermia modulates abnormal
cellular free radical production, poor calcium management, and poor pH management. In
the more delayed post-reperfusion window, hypothermia modulates the downstream
necrotic, apoptotic, and inflammatory pathways that cause delayed cell death. A
schematic illustration of these processes is provided in Figure 1.2.
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Figure 1.2: Schematic illustrating the effects of hypothermia on ischemia/reperfusion injury.
Figure adapted from Lampe et al.25 Post-reperfusion cooling (b) is thought to target only the later cell death
and inflammatory signaling. Intra-ischemia protection shown in (c) is thought to target both ischemiainduced cellular abnormalities and post-reperfusion cell signaling.

There are a number of possible mechanisms by which mild hypothermia might improve
neurological functions which include at least the following: (i) reduction in brain
metabolic rate, (ii) reduction in free radicals, (iii) blockade of excitotoxic mechanisms,
(iv) calcium antagonism, (v) preservation of protein synthesis, (vi) modulation of the
inflammatory response, (vii) apoptosis and mitochondrial dysfunction, (viii) early gene
activation, and (ix) decrease in edema formation.
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(i).

Reduction in Brain Metabolic Rate
It was originally believed that hypothermia’s sole protective benefit was due to its

ability to reduce cerebral metabolism. For every 1°C reduction in body temperature, there
is a 6 to 10% decrease in cerebral metabolism.26 This temperature dependent decrease in
metabolism results in a decreased demand for oxygen and glucose in the brain.27 The
reduction in glucose and oxygen consumption helps prevent injury caused by a limited
supply of oxygen. While there is a decrease in metabolism with hypothermia, we now
know that this is only one of the many mechanisms of hypothermia.

(ii).

Reduction in Free-Radicals
In the section 1.3, the idea that energy failure and consequential increases in

intracellular Ca2+ lead to the production of free radicals was introduced. Free radicals are
compounds with an uneven number of electrons in the outermost orbital, and as a result,
are highly reactive. The effects of free radicals are magnified upon reperfusion when free
radicals can interact with the renewed supply of oxygen to create reactive oxygen species
(ROS), such as superoxide (O2-), which are more destructive. This effect is again
magnified with the presence of NO, which is also made more abundant by increased
intracellular Ca2+. Superoxide can combine with NO to generate the highly toxic free
radical species, peroxynitrite (NO2-), which is able to rapidly diffuse across cell
membranes and affect surrounding cells. It also inactivates enzymes including
mitochondrial ATPase, inhibiting mitochondrial electron transport, which leads to cells
inability to sustain homeostasis and eventually apoptosis.
Under hypothermia condition, the release of free radicals is considerably
decreased allowing endogenous anti-oxidative mechanisms to prevent or attenuate
oxidative damage to cells28 by prevention of mitochondrial failure, reduction in
excitotoxicity and neutrophil accumulation, interleukin-1 (IL-1) mRNA upregulation and
NOS activity.
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(iii).

Blockade of Excitatory Neurotransmitters
The injured tissue releases massive amounts of glutamate which leads to the

activation of NMDA receptors and concomitant influx of Ca2+ into the cell, inducing what
is known as excitotoxic brain damage. Hypothermia significantly reduces extracellular
levels of both glutamate and glycine.28, 29 Neuroprotective properties of hypothermia may
be partly due to its ability to prevent increases in the extracellular concentrations of amino
acids that enhance the activity of the NMDA glutamate receptors and block the sustained
elevation of the extracellular glycine concentration in response to brain ischemia.29
Glycine is an inhibitory neurotransmitter in the brain stem and spinal cord. The NMDA
receptor channel cannot be activated in the absence of glycine.30 Reducing NMDA
receptor activation prevents the excessive influx of Ca2+ into the cell, thereby preventing
Ca2+-mediated neuronal damage.

(iv).

Hypothermia As a Calcium Antagonist
Intracellular calcium concentration is increased when energy fails. Calcium is

involved in the regulation of many enzyme systems inside the cell such as
Ca2+/calmodulin-dependent protein kinase II, a multifunctional enzyme complex that
mediates many of calcium’s effects and also regulates protein kinase C which plays a
pivotal role in neurotransmitter release. Reduced calcium influx might be one of the key
mechanisms underlying hypothermia-induced neuroprotection. {Sahuquillo, 2007 #613}

(v).

Protein Synthesis Preservation
The ubiquitin-proteasome proteolytic system is present in all eukaryotic cells and

is responsible for the selective degradation of misfolded or damaged proteins.
Consequently, ubiquitin plays an essential role in maintaining proper cellular functions.
Ischemia and other brain insults provoke ubiquitin depletion. One consequence of
ubiquitin deficit is excessive accumulation of abnormal proteins induced by brain injury
or secondary ischemic events. Hypothermia has been shown to promote ubiquitin
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recovery in experimental models of ischemia and could be one of the protective
mechanisms against delayed neuron death.31

(vi).

Modulation of the Inflammatory Response
In most brain injuries, an inflammatory response begins about 1 hour after

ischemia-reperfusion and persists for up to 5 days.32 Large amounts of pro-inflammatory
mediators are released inducing inflammatory and immune responses which can cause
additional-injuries. Hypothermia has been shown to suppress these reactions.33
Interrupting the inflammatory cascade can significantly attenuate the extent of brain
injury and infarct size.

(vii).

Apoptosis and Mitochondrial Dysfunction
Following neuronal injuries such as ischemia, cells may recover, become necrotic,

or enter a pathway leading to programmed cell death, or apoptosis. Several studies have
shown that hypothermia can interrupt the early stages of the apoptotic pathway, thereby
preventing cellular injury from progressing to cell death. Hypothermia appears to reduce
apoptosis by inhibiting caspase enzyme activation34 and preventing mitochondrial
dysfunction.35

(viii). Early Gene Activation
Hypothermia stimulates early gene activation which is part of the protective
cellular stress response to injury and promotes production of cold shock proteins that can
be cytoprotective in the presence of ischemic and traumatic injury.27 The relatively fast
induction of the immediate early genes such as fosB, junB and c-jun, following
hypothermia reflect a faster continuation of normal intracellular signaling, enhancing
neuronal recovery.126
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(ix).

Decrease in Edema Formation
Increased intracranial pressure (ICP) is the leading cause of death after severe

traumatic brain injury (TBI). This increased ICP reduces cerebral perfusion pressure
(CPP) and is one of the main causes of brain ischemia. Furthermore, many of the
secondary injuries progress to dysregulation of intracellular and extracellular water
content and consequently to brain edema, which both increases ICP and reduces CPP,
which ends in cell death. Hypothermia decreases the detrimental effects of injury on the
blood brain barrier and consequently decreases the formation of edema and reduces
vascular permeability.36

b)

Current Methods of Hypothermia Induction
There are two main approaches used to induce hypothermia. The first approach is

systemic or whole body cooling. The second approach is selective cooling where the
damaged tissue is cooled, while maintaining the normal core body temperature.

(i)

Whole Body Cooling
Systemic cooling induces hypothermia by lowering the core body temperature,

often by using a blanket to cool the skin surface, which has been a relatively simple and
popular method. Other whole body cooling approaches include immersing the body into
cold water, packing the body with ice, or inserting an endovascular cooling catheter.
Surface cooling cannot always be readily applicable in a clinical setting because of the
large surface area of the human body and shivering-related complications introduced with
surface cooling that may be difficult to control.37
The use of endovascular cooling eliminates complications associated with
shivering since it directly cools the blood supply while maintaining a normal skin surface
temperature. A cooling catheter can be inserted quickly, between 10-25 minutes, and the
target core body temperature, 33-34°C, can be reached more quickly than when
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hypothermia was induced using a cooling blanket.38 However, the major disadvantage of
this method for systemic cooling is that it requires invasive surgical techniques for
catheter insertion and success is highly dependent on the skills of the surgeon.

(ii)

Potential Side Effects of Whole-Body Cooling
Large decreases in the core body temperature, which are often associated with

systemic hypothermia, can lead to dangerous complications, such as development of
sclerema, skin erythema, acrocyanosis, pulmonary hemorrhage, renal failure, increased
blood viscosity, disseminated intravascular coagulation, hypoglycemia, acid-base and
electrolyte disturbances, increased risk of infections, significant cardiovascular
disturbances, and even death.39, 40 Sudden cardiac arrest and ventricular tachyarrythmia
including fibrillation have also been reported in infants who were hypothermic with rectal
temperatures of less than 34.5°C during exchange transfusion with cold blood. Even mild
hypothermia of 34-35°C has been reported to cause a marked decrease in myocardial
contractility41, which can lead to conduction disturbances, hypotension and cardiac
arrhythmia as seen in adults and newborn infants.42, 43 Moreover, hypothermia may result
in decreased leukocyte mobility and phagocytosis, and increased risk of infection,
especially pneumonia, as reported in adults.44
A recent study correlating degree of therapeutic hypothermia with fatality and
physiological disorders reported mortality rates of 39%, 52%, and 80%, respectively with
mild, moderate, and severe therapeutic hypothermia.45 Therefore, in order to avoid the
complications associated with systemic hypothermia, it may be more beneficial to apply
selective cooling. This method allows the core body temperature to remain within 3637°C while the targeted tissue temperature is reduced.

(iii)

Selective Brain Cooling
Methods for selective brain cooling (SBC) include using a cooling helmet,

epidural cooling, packing the head with ice, forced convection, nasopharyngeal cooling,
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and directly cooling the blood supplied to the brain. It has been shown that perfusing cold
saline (4°C) in the epidural space of the brain for 6 hours provided rapid and deep cooling
to the brain tissue. The brain temperature decreased to ≈ 27-30°C within 5 minutes, while
the normal core body temperature remained constant.46 Using a cooling helmet with
circulating cold water (4°C) reduced the average brain temperature 2-4°C within 2
hours47,

48

, while maintaining normal rectal temperatures. Placing a cooling device

(≈18°C) on the carotid arteries provided a 2.4°C reduction in the brain temperature of
rats, while maintaining a constant core body temperature.49
Nasopharyngeal cooling has the potential to overcome some of the limitations of
current cooling methods. Based on anatomical features, cooling the nasal cavity may offer
the capability to cool the brain selectively by cooling blood in both internal carotid
arteries (ICAs) via counter-current heat exchange mechanism with the neighboring
cavernous sinuses which collect cold venous blood from the mucosal linings of the nasal
cavities. Furthermore, cerebrospinal fluid (CSF) chilled at the basal cistern cools the
whole brain through the CSF circulation. Dohi et al., achieved a lower cooling rate of
≈2.5°C/h by blowing 24-26°C air at a flow rate of 8-12 L.min-1 directly into the nasal
cavities of two patients with Foley catheters adjunct with surface cooling.50 Furthermore,
Covaciu et al., demonstrated selective cooling of the brain (≈3°C/h) by circulating cold
(8-10°C) saline in balloon catheters placed into the nasal cavities of pigs.51 A recent study
employed transnasal evaporative cooling by spraying room temperature perfluorocarbon
liquid (perfluorohexane, PFH; F2 Chemicals) into the nasal cavities with compressed
oxygen to achieve average intra-nasal cooling rate of ≈4°C/h.52 However, use of
perfluorocarbon raises environmental and health issues. It is a greenhouse gas and
depletes the ozone layer and is listed as a toxic substance under the Canadian
Environmental Protection Act (CEPA).53 Another safety concern is the risk of coolant
aspiration which might cause lung damage over prolonged periods since neural protection
therapy may involve mild hypothermia being maintained for 72 hours.
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c)

Rewarming
Rewarming is a delicate phase of therapeutic hypothermia. Adverse consequences

of whole body rewarming may lead to secondary injury seriously limiting the protective
effects of hypothermia. Many studies demonstrated that a slow rewarming rate (0.10.4°C/hr54)

improves

clinical

outcome,

while

rapid

rewarming

may

impair

thermoregulation and exacerbate cell damage55, and have unfavorable effects on basic
hemodynamic variables.56 Significant decreases in jugular venous oxygen saturation have
been reported during rapid rewarming of patients following cardiac surgery under
hypothermic conditions, indicating hypoxia of the brain57; more slow rewarming led to a
decrease in the incidence and severity of jugular bulb desaturations. Rapid rewarming
was also recognized to cause a rebound in intracranial pressure58, as well as cause a
mismatch between increases of cerebral metabolic rate of oxygen (CMRO2) and cerebral
blood flow.59 Rapid rewarming may open the permeability transition pore in the
mitochondrial membrane, and hence result in mitochondrial dysfunction.60 Following the
rewarming phase, another important concept is the maintenance of strict normothermia,
as fever is independently linked to adverse outcome in all types of neurological injuries.
In summary, optimal cooling duration and cooling depth still remain inconsistent and
require further investigations. The general agreements among clinicians are early cooling
initiation within the treatment window after injury and gradual rewarming. These
approaches usually yield maximum neuroprotection and avoid adverse effects.

1.5 Current Methods of Brain Temperature
Measurement
Once the brain is damaged, whether by brain ischemia or physical injury, brain
temperature rises above body temperature. A typical elevation is between 1°C and 2°C.61, 62

As a result, core body temperature is not reflective of the actual brain temperature or the
efficiency of therapeutic management; therefore, having a method to measure brain
temperature non-invasively is extremely useful and important during hypothermia
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treatment. Moreover, SBC requires a method that can measure local brain temperature rather
than body temperature as the latter may not reflect the actual brain temperature . Several
approaches have been developed to assess brain temperature. Brain temperature can be

measured using infrared tympanic thermometer, zero-heat-flux thermometry, microwave
radiometry, magnetic resonance spectroscopy, and ultra-sound thermometry.

1.5.1 Tympanic Membrane Thermometry
The tympanic membrane (TM) is the boundary between the outer and middle ears,
commonly known as the eardrum and its location is proximal to the internal carotid (ICA)
artery; therefore, tympanic membrane temperature should be the same as that of blood in
the ICA supplying the brain. However, in recent publications, TM temperature was
shown to differ from brain temperature by as much as 2.5-3°C.63,

64

Such differences

might be attributable to poor thermal insulation of the measuring probe from the
surrounding ear canal and poor contact between the probe and the membrane itself. If the
sensor is not correctly positioned it may detect infra-red radiation energy emitted from the
ear canal rather than that of the tympanum.

Figure 1.3: Tympanic thermometer.65
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1.5.2 Zero-Heat-Flow Method
Zero-heat-flux (ZHF) method is another technique to measure tissue temperature
by inducing an isothermal zone under the sensor by heating the skin surface in a way that
the outward heat flow from the core is matched with inward heat flow from the surface.66
The ZHF probe actively heats the tissue until no temperature gradient exists across the
probe. When an equilibrium is reached there is a region of tissue below the surface which
has a uniform temperature. The thermometer probe consists of two temperature sensors
separated by an insulating pad, which also houses a heating element. One of the sensors is
in contact with the patient’s forehead and the other one faces away from the forehead. A
surface heating element is placed on top, along with another layer of insulation, switching
on or off depending on the direction of the temperature gradient between the two sensors.
The temperature on both sides of the layer is continuously monitored; when the sensors
eventually reach the same temperature, no additional heat can flow out through the pad
and the deep body temperature is inferred by the temperature of the skin sensor.

Figure 1.4: Principle of the zero-heat-flux (ZHF) method.
Figure adapted from Dittmar et al.67

Recently, it has been shown that ZHF method accurately reflects core temperature during
mild hypothermia in patients after cardiac arrest with accuracy of ∼ ±0.5°C compared to
core temperature.68,

69

A potentially serious problem is the possibility of inducing an

increase in brain temperature during its operation in hypothermia treatment.70
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1.5.3 Magnetic Resonance Thermometry
The application of magnetic resonance (MR) to noninvasive thermometry of
biological tissues is based on the effects of temperature on proton density, relaxation
times T1 and T2, the water diffusion coefficient and the water proton resonance frequency
(PRF).71 Among these parameters, the chemical shift of the water proton has been
recognized as the most reliable and practical indicator of temperature.72 Three methods,
phase mapping, single-voxel spectroscopy and spectroscopic imaging (SI), have been
proposed for measurement of temperature using proton chemical shift.
In

phase-difference

PRF

thermometry,

phase

maps

acquired

before

heating/cooling (referred to as the baseline phase maps) are subtracted from phase maps
measured after treatment. Temperature differences are calculated based on phase
variations with respect to a reference baseline.73 Since there is a temporal delay between
the current and the baseline acquisition, this method is very sensitive to motion artifacts.
However, referenceless phase-difference methods74 were proposed to remove motion
artifacts by assuming that the thermal changes are localized to a small and well defined
area. The method requires prior knowledge of where the temperature change will occur.
Obviously, these assumptions are not applicable in the case of global brain cooling. The
second group of PRF techniques uses magnetic resonance spectroscopy (MRS) or
magnetic resonance spectroscopic imaging (MRSI) acquisitions to measure changes in
water spectral line position. Motion and magnetic susceptibility artifacts can be reduced
using an internal temperature-independent metabolite resonance. N-acetylaspartate
spectral line at ~2 ppm is most often used for the brain. However, the long measurement
time (typically in the order of a several minutes) and poor spatial resolution limit its
application, even when applying a fast technique such as echo-planar spectroscopic
imaging. Weis et al have recently compared two magnetic resonance methods, phasedifference and MRSI methods with high spatial resolution, for monitoring brain
temperature changes during cooling on ten healthy volunteers. Mean brain temperature
reduction varied in the interval 0.6-3.0°C and 0.7-2.7°C as measured by the MRSI and
phase-difference methods, respectively.73 The main advantage of the phase-difference
technique is its simplicity and rapid measurement acquisition time. The disadvantage lies
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with the phase wrapping that can complicate measurements in the areas containing fat
tissue or in those regions with increased magnetic field inhomogeneity. The MRSI
technique avoids the phase-wrapping problem and is able to separate water and fat signals
for temperature measurement in tissues that contain fat. However, the disadvantage of this
technique lies with the prolonged measurement acquisition time, more complicated data
processing and the need to transfer patients to imaging facilities.73

1.5.4 Microwave Radiometry
Microwave radiometry (MWR) technique use the tissue temperature-dependence
of the power of the natural blackbody thermal radiation emitted from body tissues.75
Lossy dielectric materials such as human body tissues are partially transparent to
microwave radiation in the frequency range from 1-4 GHz allowing the measurement of
temperature at a significant depth within the body.76 For brain tissue, the effective depth
is tens of millimeters and changes with frequency. By measuring temperatures in several
microwave frequency bands, the internal temperature profile can be estimated from the
data by solving an inverse problem. Han et al., have developed a five-band microwave
radiometer to measure the brain temperature of infants during hypothermia therapy
demonstrating an accuracy of ±0.75°C.77 There are several issues in the application of
MWR to the measurement of deep brain temperature. These problems include relatively
poor temporal and spatial resolution of the measurements and systemic errors arising
from inaccuracies in model parameters.78

1.5.5 Ultrasound Thermometry
Ultrasound is an attractive modality for temperature monitoring because it is
inexpensive and has relatively simple signal processing requirements. This modality may
be useful for temperature estimation if a temperature-dependent ultrasonic parameter can
be identified, measured and calibrated. The use of echo shifts has received the most
attention in the last decade. It has been shown that by measuring the time shift of received
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echoes and tracking scattering volumes, the temperature from a region of interest can be
predicted. However, prior knowledge of both the speed of sound and thermal expansion
coefficients are necessary, which limits this technique for temperature measurement.79
Moreover, acoustic attenuation is also dependent on temperature, but with significant
changes occurring only at temperatures above 50°C.80 Minimal change in attenuation
below this temperature range reduces its attractiveness for use in clinical applications.
The major disadvantage of this technique is inducing temperature increase, which limits
the protective effects of hypothermia. Fater et al. demonstrate a good correlation of tissue
heating and transcranially transmitted ultrasound of mid-kilohertz range (340 kHz). They
showed that brain temperature increased within 2 to 5 minutes of insonation with average
elevation of 0.9°C with 7 W/cm2.81

1.6 Near-Infrared Spectroscopy
Optical methods are a promising alternative to the aforementioned techniques
since they are safe and the instruments are compact and portable. Biological tissue is
relatively transparent to NIR (650-100 nm) light due to the low optical absorption
coefficient in this region. The major absorbing chromophores in the NIR include water
(H2O) and oxy- (HbO2) and deoxyhaemoglobin (Hb). Figure 1.5 displays the specific
absorption spectra of H2O, HbO2 and Hb in the NIR range.
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Figure 1.5: Specific absorption spectra of H2O, Hb, and HbO2 in the NIR range. Values for H2O are
adjusted by a factor of 10, for illustrative purposes. Extinction coefficients of pure water and oxyand deoxy-hemoglobin were taken from literature.82

1.6.1 Optical Characteristics of Tissue
Biological tissues are comprised of a vast assortment of molecules organized in
different structures and functional units. There are four independent macroscopic
parameters that are believed to characterize light propagation in tissue: the index of
refraction (n), the absorption coefficient (μa), the scattering coefficient (μs), and the
scattering anisotropy (g).
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1.6.2 Light Scattering in Tissue
The ability to perform quantitative spectroscopy is complicated by the high-scatter
nature of tissue. Scattering can be defined as the dispersion and redirection of wavelets in
the medium of transmission. Scattering and light redirection can occur when light is
incident on small particles (Rayleigh scatter), larger structures (Mie scatter), and at
interfaces between media of differing indices of refraction (Fresnel reflection). As light
propagates through tissue, it interacts with cell membranes, tissue boundaries, and
organelles; at each interface, light is reflected and refracted by these objects, and
therefore experiences a deviation in trajectory. When NIR light is used to interrogate
biological tissue, all three major modes of light redirection can occur multiply and in
combination. In fact, scattering events far outnumber absorption events, where the main
light scattering components of cerebral tissue are lipoproteins found in cell membranes,
followed by mitochondria and other cellular components.83
The definition of mean free path (MFP) is the mean distance that a photon travels in the
medium of tissue before it is absorbed, (absorption MFP: la) or scattered (scattering MFP:
ls). The reciprocal of a MFP is the corresponding of absorption or scattering coefficient (
μa = 1 / la, and μs = 1 / ls).
The anisotropy factor g is defined as:

(1-1)

where

, and

is the distribution pattern of possible

deflection angles of a photon scattered by a particle. These optical parameters should
provide some information about the biomedical properties as well as the morphological
and structural configurations of tissue. The reduced scattering coefficient μs′ is then
defined as:
(1-2)
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The purpose of
1/

is to describe the diffusion of photons in a random walk of step size of

where each step involves isotropic scattering. It follows that the transport

attenuation coefficient is the sum of both absorption and reduced scattering coefficients:
. In NIR range, since
addition, the wavelength dependence of

, it is usually assumed that

. In

is well approximated by the so called power

law:
(1-3)
where A and b are constants either empirically determined or predicted by Mie theory,
depending on the application.84

1.6.3 Light Absorption in Tissue
The absorption coefficient (μa) describes the effectiveness of light absorption by a
chromophore. When light radiation is incident on matter composed of discrete electrical
charges, the charges are forced to oscillate at the frequency of the incident electric field.
When infrared radiation is incident on a system of matter, resonance will occur, whereby
energy is transferred from the incident field to the system and its amplitude of vibration is
greatly increased. The excited state of the atoms or molecules usually lose their energy by
colliding with one another within 10-12 seconds, thereby raising the kinetic energy of the
other particles involved in the collisions. Hence, the energy associated with the incident
field is most often dissipated as heat within the medium. This process is known as
absorption.
The overall effect of absorption is a reduction in the intensity of the light beam travelling
the medium. A relationship between the absorption of light in a purely absorbing medium
and the thickness of the medium was first determined as the Beer-Lambert law
I  I 0 e .C.L  I 0 e a .L in base of e or

I  I 010 .C.L in base on 10

(1-4)
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where I0 is the incident intensity, I is the transmitted intensity, (the log ratio of which is
the attenuation of light), C is the chromophore concentration, L is the path length of light
through the medium, and α and ε is known as the specific absorption coefficient for base
of e and 10, respectively. The ability to perform spectroscopy in-vivo relies on the fact
that there are few absorbers of NIR light in biological tissue allowing adequate light
penetration of the tissue. The chief endogenous absorbers are water, oxygenated
hemoglobin, deoxygenated hemoglobin and lipids.

a)

Water
The average water content of neonatal brain is estimated to be 85 % of the mass of

the brain and 80 % of the adult brain.85 Because of its high concentration in most
biological tissues, water is considered to be one of the most important chromophores in
tissue spectroscopy measurements. The extinction coefficient for water shows a general
trend of increase with increasing wavelength. Between 600 and 900 nm there exists a
region of relatively low absorption. Within this NIR range (600-900 nm), water has two
distinct features in its absorption spectrum: one at 740 nm and another at 840 nm. Above
900 nm the absorption coefficient increases fairly rapidly to a peak at about 970 nm. In
fact, for wavelengths of light greater than 900 nm, absorption by water is strong enough
to limit the propagation of light to less than 1 centimeter, effectively forming the upperlimit on what is termed the "optical window" of NIR. Within tissue, water binds to a
variety of molecules such as other water molecules, proteins (collagen, myosin, actin),
mineral deposits in bone and phospholipids bilayers. The hydrogen bonding with these
molecules changes the NIR spectral features derived from O-H vibrations.

b)

Hemoglobin
Hemoglobin is the strongest endogenous absorber of NIR light. Hemoglobin is a

large iron-containing protein found only in the blood, and constitutes approximately 4045% of the whole blood. It is responsible for delivering oxygen from the lungs to body
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tissues and returning waste gases, such as carbon dioxide, to the lungs to be exhaled.
Carbon dioxide is transported in the blood from the tissue to the lungs by one of three
methods86: (i) About 5-7% is dissolved directly into the blood (ii) 10% binding to
proteins, particularly haemoglobin; and (iii) 85% carried as a bicarbonate ion. Both Hb
and HbO2 exhibit strong absorptions at wavelengths shorter than 600 nm: effectively
placing a lower-limit constraint on the range of wavelengths suitable for tissue
interrogation. Another feature to note is the isosbestic point where the specific extinction
coefficients of these two forms of hemoglobin are the same. Within the NIR range, the
specific absorption spectra of Hb and HbO2 cross at 800 nm but the marked differences
between them at other NIR wavelengths have allowed the determination of tissue blood
oxygenation with NIRS. The temperature-dependent changes of the hemoglobin NIR
absorption spectra have been investigated87, 88. It has been shown that by increasing the
temperature in the range of 20-40°C, the amplitude of Hb and HbO2 decreased by 0.150.18% °C-1 and less than 0.05% °C-1 and shifted by 0.08 nm °C-1 (red-shifted for 760nm)
and 0.15 nm °C-1, respectively.87 The amplitude changes in Hb are likely to have more
significant effect on the total absorption in the range of interest than those for HbO2.

c)

Lipids and Other Absorbing Compounds
Lipids constitute about 5% of the total wet weight of a newborn infant’s brain.

This percentage increases to 8% of the grey matter and 17% of the white matter in
adulthood. The specific absorption of NIR light by lipids is similar in magnitude to that of
water. Lipid will not significantly add to the overall extinction coefficient of brain tissue
as it is only present at approximately one tenth the proportion compared to water. Other
negligible absorbers include some other enzymes involved in cellular respiration and
some proteins found in blood plasma, none of which are abundant enough to contribute
significantly to in-vivo spectroscopy.
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1.6.4 in-vivo spectroscopy
The aim of NIR spectroscopy is to quantify the concentrations of these
chromophores in tissue, and this requires the ability to separate the effects of absorption
from those of scattering. Fundamentally, the coefficients of absorption (μa) and reduced
scattering

can be determined by a series of reflectance measurements performed in

one of three domains, namely, time89 (with a fast pulse of light), frequency90 (with a
sinusoidal modulated source of light), and steady state or continuous wave (CW)91 (with a
source of constant intensity). These three techniques are illustrated schematically in
Figure 1.6.

Figure 1.6: Schematic illustration of the three main types of NIRS instrumentation.
Figure adapted from Delpy et al.92

Associated with each type of instrumentation is an equally wide range of types of
measurements that can be made with them. Quantitative NIRS of the brain can essentially
be separated into four subfields: spatially resolved spectroscopy, second derivative NIRS,
frequency-domain and time-resolved spectroscopy. For a complete review of these
techniques see Delpy et al.92 In spatially resolved spectroscopy simultaneous
measurements of attenuation at multiple distances are combined to obtain sufficient
information, to separate absorbance and scattering properties at spatially resolved
locations.93 Derivative of light attenuation with respect to optode spacing can be used to
derive the product of the optical properties, i.e., μa

. If the wavelength dependence

of the reduced scattering coefficient is known for the tissue of interest then the absorption
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coefficient can be calculated and presumably used to calculate absolute concentrations of
chromophores.
Second

derivative

spectroscopy

technique

can

estimate

chromophore

concentrations from an attenuation spectrum, by approximating a linear relationship
between the measured attenuation and absorption of the medium. The dominant term in
the second-order derivative of attenuation spectrum with respect to wavelength is the
product of the differential pathlength, and the second derivative of the chromophore
absorption spectra. Regressing the derivative chromophore spectra on to the derivative
attenuation spectrum will yield the product of pathlength, and concentration for each
chromophore. Concentrations of chromophores can be evaluated based on two
assumptions: that the water concentration of the tissue of interest is constant and the
tissue is homogeneous.94
Frequency-domain (FD) techniques modulate the intensity of a light source at
radio frequencies to produce the diffuse photon density wave that propagates through the
tissue.95 The phase and amplitude of this wave are measured at the detector which allows
calculation of the optical pathlength and enables conversion of changes in attenuation to
changes in absorber concentrations. Time-resolved NIR methods are photon counting
techniques that use a laser light source to emit pulses of monochromatic light and fast
detectors to measure the time-of-flight of each detected photon (i.e., the time required for
a photon to travel from the laser to the photomultiplier tube). This process is repeated,
typically at a frequency of around 80 MHz until about 107 photons are measured, and
temporal point spread function (TPSF) is generated. Furthermore, by fitting the TPSF to
an appropriate model of light transport, values for both the absorption and reduced
scattering coefficients can be estimated and absolute concentrations of absorbers can be
calculated. Time-resolved spectroscopy was the technique of choice for the work
completed in this thesis. This section will be followed by reviewing the previous studies
which have utilized NIRS to measure temperature.
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1.6.5 Temperature Monitoring by Near-Infrared Spectroscopy
There are a number of studies that have investigated the temperature dependent
effects on tissue water NIR spectra. As pure water is heated the fraction of hydrogen
bonds are reduced through thermal agitation of the water molecules, which overcomes the
force of the hydrogen bonds. This in turn produces a blue-shift of the water absorption
peak. The water NIR absorption peaks around 740, 840 and 970 nm decreases in
amplitude by approximately 0.5-0.8%°C-1, and shifts towards higher wavelengths with
decreasing temperature; an approximate shift of 5-10 nm (easiest to see in the 970 nm
band) has been reported over the range 30-40°C.96 Water absorption spectra as a function
of temperature are shown in Figure 1.7. These temperature dependent spectral shifts are
due to decreases in the extent of intermolecular hydrogen bonding by water molecules
with increasing temperature.
Hollis et al. investigated the use of an optical technique to measure tissue
temperature. They used a broadband CW technique to measure reflectance over the
spectral range of 650-980 nm. Within this spectral window water absorption peaks are
located at ~740, ~840 and ~976 nm. The primary focus of their work was on the
absorption peaks at 740 and 840 nm because the lower absorption of these peaks relative
to the 976 nm peak allows for deeper penetration of light. They used the technique of
principal component regression (PCR) to calibrate the temperature response of pure water
spectra in order to determine dominant spectral features associated with temperature
changes that could then be used for fitting the tissue temperature. Measurements
performed on an adult forearm had a standard error of prediction of ~1.2°C for the
recovered temperature. Hollis concluded that in order to improve results scattering should
be accounted for and that using the water peak at ~976 nm would provide more contrast
although it would limit the light penetration depth in the tissue.96 Chung et al. have also
demonstrated a method that employs broadband diffuse optical spectroscopy (DOS) to
measure tissue temperature based on resolving water vibration frequency shifts in NIR
water absorption spectra that occur with changes in temperature and macromolecular
binding state. DOS acquires scattering-separated absorption spectra, typically from 650 to
1000 nm, using a combination of frequency domain and steady-state reflectance and
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provides an absolute measure of absorption, unlike conventional reflectance methods. The
method focuses on the ~976 nm water peak for greater contrast in temperature and uses
the temperature isobestic point at 996nm, in which the specific absorption spectra of
water at different temperature is constant, to separate the macromolecular bound water
contribution from the thermally induced spectral shift which requires quantifying subtle
changes in the NIR water absorption features and a high-resolution calibrated
spectrometer. This method has been tested in tissue simulating intralipid phantoms. The
average difference between optical and thermistor measurements was ~1.1 ± 0.91°C in
the temperature range of 28-48°C.97, 98

Figure 1.7: NIR absorption spectra of pure water at various temperatures. Extinction coefficients of
pure water as function of temperature were taken from literature. 82
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1.7 Cerebral Blood Flow and Cerebral Metabolic Rate
of Oxygen
As discussed in detail in the section 1.4.1, one of the important mechanism of HTinduced neuroprotection is the preservation of brain ATP levels resulting from a reduction
in cerebral metabolism or metabolic rate of oxygen (i.e. CMRO2).99 The effects of HT on
CBF are a consequence of the well-accepted phenomenon that CMRO2 is closely coupled
to CBF and therefore, a reduction in the former is coupled to a reduction in the latter.100,
101

Preserving the coupling between CBF and CMRO2 is an important factor in the control

of the cerebral circulation, connecting the change in metabolic demands with the supply
of substrates by blood flow. As a consequence of this balance between flow and
metabolism, the oxygen extraction fraction (OEF) indicates any regional variation in
brain. As such, it is critical to measure these key physiological parameters throughout
therapeutic hypothermia, particularly during rewarming phase. Rapid rewarming of the
injured brain commonly leads to a mismatch between cerebral metabolism and
perfusion59 and can cause in rebound intracranial pressure elevations58, cerebral venous
desaturation102, and brain ischemia. It is suggested that controlling the rewarming rate as
low as 0.1-0.4°C/hour is preferred to reduce the neurological risks.54 Therefore,
predicting and managing possible systemic side effects of rewarming is also important for
guaranteeing HT efficacy.

1.7.1 Current Techniques
CBF can be defined as the blood volume travelling through a given amount of
brain tissue in a given amount of time. All methodologies require the use of a tracer,
whether introduced or endogenous, diffusible or intravascular with the various imaging
modalities that include positron emission tomography (PET), Xe-enhanced computed
tomography (XeCT), perfusion CT (PCT), and magnetic resonance imaging (MRI).
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PET is diagnostic tool that provides quantitative information on a variety of
hemodynamic parameters such as CBF, cerebral blood volume (CBV), OEF and glucose
metabolism. PET has evolved to be considered the gold standard for studying cerebral
hemodynamics. Tracers are being used for CBF measurements are

15

O2, C15O2 and

H215O.103 The other tracer is 18F in fluorodeoxyglucose which is used to monitor glucose
consumption in cancer evaluation.104 Data acquisition takes typically 5-10 minutes and it
takes another 5-10 minutes to obtain a processed CBF map. The main advantage of PET
is the accuracy and reproducibility of its results. However, PET imaging involves the
injection of radioactive tracers, which limits its repeatability and application in healthy
volunteers. Among other limitations are low temporal and spatial resolution, low signalto-noise ratio (SNR), as well as the requirement for a cyclotron. PET allows
quantification of CBF by measuring either the delivery or clearance of radioactively
labeled water. To measure the delivery of the agent with PET,

15

O-labeled water is

injected into the subject's blood stream and emission data is acquired. To measure agent
clearance, the subject breathes 15O-labeled CO2. When CO2 is absorbed in the blood, the
15

O exchanges with oxygen of water, and this

15

O-labeled water perfuse the brain tissue.

Upon cessation of the CO2 inhalation, the clearance of the agent is measured several
minutes. Tracer clearance occurs by radioactive decay of the labeled water and physical
clearance by means of the local blood flow.
XeCT is a diffusible tracer technique that provides quantitative CBF by
administering Xe via inhalation and using the time-dependent concentration of Xe in
tissue as a measure of perfusion. After Xe is inhaled, it crosses the blood-brain barrier and
diffuses into cerebral tissue.105 CBF is then measured by determining the Xe clearance
rate from the brain using the Kety-Schmidt model106, which describes the relationship of
CBF to the tracer blood/brain partition coefficient and tracer concentration in the brain
and arterial blood. Because XeCT requires specialized equipment, is expensive, and
necessitates that an anesthetist be present during the procedure107, perfusion CT (PCT) is
more often used clinically.
PCT measurements depend on the injection rate and cardiac output108 and have
proven to be clinically useful for analysis of CBF, CBV, and mean transit time. 109 When
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combined with acetazolamide, perfusion CT can yield analysis of the cerebral vascular
reserve (CVR), thus enabling an extensive evaluation of cerebral hemodynamics.110 PCT
can accurately give a quantitative index of CBF that is comparable with the gold standard,
PET. Compared with PET, PCT provides for shorter examination times111, offers higher
spatial resolution103, and provides a simple acquisition.
The two types of MRI measurement of blood flow are arterial spin labeling (ASL)
MRI112 and dynamic susceptibility contrast (DSC) MRI113. In DSC imaging a
paramagnetic material such as gadolinium-DTPA produces dephasing in a small area
around the tracer in its first pass and as it moves in vessels it affects the T 2* in adjoining
tissues. Perfusion can be measured based on the change in the MR signal. To measure
absolute quantitative values, the arterial input function (AIF) is required. AIF is the
concentration-time curve of the tracer in the artery supplying the tissue. The technique
requires fast imaging sequences such as echo planar imaging (EPI). Images are taken in
the rate of 500 ms to 2 seconds per single image. The major drawback to produce
quantifiable data is the lack of robust arterial input and venous output functions. The
difficulties with obtaining robust measurements of arterial or venous curves in perfusion
MRI relate back to the problems of signal-to-noise, image contrast, spatial resolution.
ASL uses water as an endogenous diffusible tracer. In this technique, arterial blood water
protons are labeled proximal to the region of interest by applying radiofrequency pulses
to invert the spins. The labeled water then travels throughout the vasculature into the
capillary bed, where it exchanges with tissue water. Thus the tissue water is partially
saturated when the voxel is imaged, causing a reduction in the signal intensity
proportional to the amount of labeled water in that voxel. By subtracting the labeled
image from a control image, in which there is no labeling of water spins, the relative CBF
can be determined for each voxel in the imaging plane. The difference between labeled
and control acquisitions is about 1% of the control signal intensity. The method suffers
from low signal to noise ratio.
Bedside techniques for monitoring CBF include transcranial Doppler (TCD)
ultrasonography114, and thermal diffusion115 and laser Doppler flowmetries.116 However,
TCD ultrasonography is used for global CBF investigation and limited to observations of
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large vessel flow velocities, which do not necessarily reflect microvascular perfusion in
patients with cerebrovascular disease117, and both thermal diffusion and laser Doppler
flowmetries are invasive. Furthermore, one technique that is commonly used in animal
studies makes use of microspheres. Microspheres are small polymer or ceramic beads,
typically labeled with radioactive material, which are injected into the blood stream. By
creating microspheres that are smaller than the diameter of arterioles, but larger than the
capillary diameter, the microspheres become trapped in the capillary bed. In animal
models, the tissue can be sectioned, and the detected radioactivity from each tissue
section is proportional to the CBF.
Optical methods are promising alternatives to these current techniques since they
are safe, the instruments are compact, portable and can provide physiological
measurements at the bedside of patients. The methods employed for measuring CBF and
CMRO2 in this thesis rely on the administration of a non-diffusible, intravascular tracer.
Consequently a review of the theory behind this technique is warranted.

1.7.2 Cerebral Blood Flow Measurement by NIRS
The NIRS technique presented in this thesis to measure hemodynamic information
rely on a bolus injection of a contrast agent. The transport of the tracer through the
microvasculature of the tissue can be described by constructing a kinetic model and
applying it to time-dependent measurements of the tracer concentration. For example,
blood flow in brain, CBF, can be calculated using an intravascular tracer if the timedependent concentration of tracer in the brain, Q(t), in the arterial and the venous blood
draining the brain, Ca(t) and Cv(t), are measured. In this case, the following expression
describes the dynamic behaviour of the tracer

(1-5)

where t represents a dummy time variable to integrate over. Application of equation (1-5)
for calculation of CBF is hindered by difficulties associated with measuring Cv(t). Tissue
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vascular bed can be considered as a mesh of microvessels supplied by a single input and
draining to a single output, where each possible path from the artery to the vein has a
specific transit time (amount of time required for tracer to travel from input to output in
the tissue region of interest (ROI)). In this case, the concentration of tracer in the tissue at
a given time point is a function of its collective path through the capillary bed, as well as
the arterial input function. By definition, h(t) is the distribution of transit times of the
system. Based on this theory, the venous output can be represented as follows:

(1-6)

where u is a dummy variable in the convolution. Equation of (1-5) can be rearranged as
follows:

(1-7)

where * represents the convolution operator. The impulsed residue function, R(t), can be
defined as follows:

(1-8)

and is the proportion of tracer in the system as a function of time when an impulse
function is the input. Substituting R(t) for h(t), equation (1-7) can be rewritten:
(1-9)
Q(t) and Ca(t) are the amount of ICG in the brain and arterial blood, respectively, and
[CBF.R(t)] is the flow-scaled impulse residue function or R(t). The function CBF·R(t) can
be extracted from the arterial and tissue contrast concentration curves using a
deconvolution algorithm.118 The initial height of the derived function is CBF, since by
definition R(0)=1, and the area under the curve is the cerebral blood volume (CBV).119
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1.7.3 Cerebral Metabolic Rate of Oxygen Measurement by
NIRS
Measurements of CMRO2 were calculated120 using Fick's principle as follows:

(1-10)

The difference between the arterial concentration of oxygen, [O2]a, and the cerebral
venous concentration of oxygen, [O2]v, is commonly referred to as the arterial-venous
difference of oxygen (AVDO2), or the difference between the O2 concentration of the
arterial blood feeding the tissue of interest and O2 concentration of the venous blood
draining the tissue of interest. Equation (1-10) can be further expanded as follows121:
(1-11)

where

] is total hemoglobin concentration which can be measured from arterial

blood samples.

are arterial and venous O2 saturation, respectively. The

constant 1.39 is the O2 carrying capacity of hemoglobin measured in milliliters per gram
of Hb. Note that the dye densitometer also provides continuous measurements of
while

,

was determined indirectly from the NIRS measurements of average tissue

cerebral blood oxygen saturation,

. This technique relies on the assumption

that there exists a stable arterial-venous blood ratio in the CBV, i.e.
(1-12)

where

represents the fraction of arterial blood in CBV. The relative distribution of

arterial and venous compartments is generally accepted to be approximately 25% and
75% in the total CBV, therefore to measure
tissue cerebral blood oxygen saturation, i.e.,

was set to 0.25.122,

To obtain

, cerebral hemoglobin (HbO2,

Hb) concentrations can be calculated with the NIRS technique.
calculated as follows:

123

can then be
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(1-13)

Using this relationship, a new expression for
of

can be derived that is independent

:

(1-14)

The fraction of oxygen extracted from arterial blood into the brain, OEF, can be
calculated with the method described by Brown et al120:

(1-15)

The tight coupling of CBF and CMRO2 in the normal brain leads to a fixed level of OEF
around ~33%.124 A decoupling of the two, signifies oxidative stress, as in ischemia, and
would lead to an increase in OEF beyond the normal value of ~33%.125

1.8 Thesis objectives
The objectives of the work presented in this thesis are to develop a neuroprotection
method for neurological emergencies by inducing brain hypothermia quickly and
selectively to avoid adverse complications from whole body cooling and NIRS methods
for monitoring the brain temperature and neuroprotective effects of hypothermia during
cooling.
This work comprised of the following projects whose goals are to
(i). Develop an effective, safe, simple and fast nasopharyngeal cooling method to
selectively reduce and maintain brain temperature in the range of mild hypothermia
(32-35oC) while maintaining the whole body (rectal) temperature above 35oC.
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(ii). Develop a TR-NIR technique to measure local brain temperature which can be used
at the bedside of patients.
(iii). Evaluate the utility of TR-NIR for measuring cerebral blood flow (CBF) and
cerebral metabolic rate of oxygen (CMRO2) and in particular their ratio oxygen
extraction efficiency (OEF) as a surrogate marker of oxidation status of the brain
during hypothermia and investigates the effects of different anesthetic regimes and
temperatures on CMRO2:CBF in the normal brain.
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Chapter 2
Feasibility of Selective Brain Cooling Using a
Nasopharyngeal Method in Piglets
This chapter is adapted from the work entitled “Feasibility of Selective Brain Cooling
Using a Nasopharyngeal Method in Piglets” by M Fazel Bakhsheshi, EE Stewart, JH Tai,
L Keenliside and TY Lee, submitted to the Journal of Critical Care Medicine. The focus
of this paper is to investigate the feasibility of cooling selectively the brain of normal
new-born piglets with developed temperature regulation by spraying normal or
humidified cooled air into the nasal cavities.

2.

Introduction
Clinical investigators have reported that mild and moderate hypothermia can be

neuroprotective to reduce brain injury and decrease death and disability for a variety of
acute brain injuries following severe head trauma, cardiac arrest, stroke and neonatal
asphyxia.1-3 The neuroprotective benefits of hypothermia have been linked to the time to
initiate cooling after injury, depth of cooling and re-warming rate.4,

5

Clinical studies

indicate that the temperature range associated with better outcomes appears to be 3235°C6, 7 and has to be achieved as quickly as possible.8, 9 However, cooling the whole
body below 34°C can cause complications including , shivering, sclerema, skin erythema,
renal failure, coagulopathy, pulmonary hypertension and increased mortality.10,

11

Moreover, it may decrease perfusion and oxygenation by impairing myocardial
contractility, reducing cardiac output and making myocardial muscle more prone to
arrhymia12,

13

; as well as causing pulmonary vasconstriction and increasing blood

viscosity.14, 15 Such complications along with other ones offset the benefits accrued from
the neuroprotective effects of hypothermia. Therefore, in order to avoid the complications
associated with systemic hypothermia, it is very important to develop a selective brain
cooling (SBC) approach that can be initiated as early as possible to reduce the
temperature of the brain tissue uniformly.
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Based on anatomical features, blowing cold air into the nasopharynx may offer the
capability to cool the brain selectively by cooling blood in both internal carotid arteries
via counter-current heat exchange mechanism with the neighboring cavernous sinuses
which collect cold venous blood from the mucosal linings of the nasal cavities.
Furthermore, cerebrospinal fluid (CSF) chilled at the basal cistern cools the whole brain
through the CSF circulation (Figure 2.1). In the present study, we evaluate the feasibility
and efficiency of nasopharyngeal SBC by blowing room temperature or cold air (medical
air) into the nostrils at two different flow rates on normal new-born piglets with
developed thermal regulation.

Figure 2.1. (a) Cerebral blood and brain are chilled by heat exchange between internal carotid
arteries and cavernous sinuses and; (b) cerebrospinal fluid also cools the whole brain through the
circulation.
Figure (a) adapted from Bhatti et al.16
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2.1 Materials and Methods
2.1.1 Animals preparation and experimental procedure
Experiments were conducted on thirty-two piglets. All animal experiments were
approved by the Animal Use Subcommittee of the Canadian Council on Animal Care at
the University of Western Ontario. Newborn Duroc cross piglets were obtained from a
local supplier on the morning of the experiment. Piglets were anesthetized with 3-4%
isoflurane during preparatory surgery. A tracheotomy was performed and the piglet was
ventilated with a volume-controlled mechanical ventilator to deliver oxygen/medical air
mixture (2:1). A femoral artery was catheterized to monitor heart rate (HR) and mean
arterial blood pressure (MAP) and to intermittently collect arterial blood samples for gas
(paCO2, paO2), pH and glucose analyses. Arterial CO2 tension (paCO2) was monitored
throughout the experiment, either directly by blood gas measurements or by the end-tidal
CO2 tension, and maintained at normocapnia between 37-42 mmHg by adjusting the
breathing rate and volume. Arterial oxygen tension (paO2) was maintained at a level
between 90-130 mmHg by adjusting the ratio of oxygen to medical air. Blood glucose
was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of 25%
glucose solution was administered intravenously. Rectal temperature was recorded from a
rectal probe inserted to 3-4 cm from the anal margin. Deep brain temperature was also
measured continuously with a thermocouple probe. A burr hole 1.5 cm posterior to the
bregma along the mid-line was made in the skull with a Dremel tool. The needle
thermocouple probe was inserted through the burr hole into the brain to a depth of 2 cm
from the brain surface to measure brain temperature. After surgery, each piglet together
with a recirculating heated water blanket were wrapped with linen blankets, maintained
on 1-2% isoflurane, and randomized to receive one of four different nasopharyngeal
cooling treatments which involved blowing either room or cold air at either one of two
flow rates into both nostrils of piglets:
I.
II.

Room temperature at a flow rate of 3-4 L.min-1(n=6);
-1 ± 2°C at a flow rate of 3-4 L.min-1(n=6);
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III.

Room temperature at a flow rate of 14-15 L.min-1(n=6);

IV.

-8 ± 2°C at a flow rate of 14-15 L.min-1 (n=9)

To control for the normal thermal regulatory response of piglets without nasopharyngeal
cooling, a control group of piglets (n=5) had their brain temperature monitored without
nasopharyngeal cooling.

2.1.2 Method of nasopharyngeal brain cooling
Nasopharyngeal brain cooling was achieved by directing room temperature or
cooled air via a catheter in each nostril into the nasal cavities. Each catheter was
lubricated with 2% lidocaine gel for anaesthesia and inserted 4-5 cm into each nostril. Air
was delivered into the nasal catheters from a pressurized tank through a flow regulator, a
pump and a cooling unit (Polyscience refrigerated/heated circulating bath). The circuit
was customized by replacing the pump tube with a double-walled tube with circulating
cooling liquid (Ethylene glycol) in the outer tube and directing air through the inner tube
(Figure 2.2). Before starting the cooling process, the cooling unit was set to -25°C with a
temperature stability of ±0.05°C over 30-45 min; the same settings were kept during the
entire experiment. Induction of hypothermia was initiated by directing air at the required
temperature, either -1 ± 2°C or -8 ± 2°C measured at the tip of the nasal catheter and flow
rate, either 3-4 or 14-15 L.min-1, into the nasal catheters. Once the brain temperature
stabilized, the flow rate was decreased to 0.5-1.5 L.min-1 to maintain the lower
temperature reached. Before the onset of hypothermia induction, the core temperature of
all animals was stabilized at 38 ± 0.5°C for an hour by turning the recirculating heated
water blanket on and off.
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Figure 2.2. Schematic representation of the cooling circuit used for nasal cooling. The 7 Litre
container was filled with a cryogenic cooling liquid (Ethylene glycol).

2.1.3 H&E histopathological examination
The piglets were sacrificed at the end of the experiment by intravenous injection
of potassium chloride (1-2 ml/kg) while on 5% inhaled isoflurane. For each piglet, the
brain and the snout were excised. Coronal sections of the brain (cut into the 4-5 mm-thick
sections) and the snout (at the region of the premolar tooth) were obtained. The tissue
sections were fixed in 10% neutral buffered formalin for 24~48 hr, and then transferred
into a phosphate buffer saline (PBS) solution for preservation. These tissue fragments
were then paraffin-embedded, cut into 5 µm-thick sections and stained with Hematoxylin
and Eosin (H&E) for histopathological examination.

53

2.1.4 Statistical analysis
SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses.
Normality of the distribution of the measurements was verified using Kolmogorov–
Smirnov (KS) test. Analysis of variance (ANOVA) was used to check the difference
between the groups. Comparisons between time-based measurements within the groups
were performed with analysis of variance repeated measurements. Statistical significance
was based on p-value < 0.05. All data are presented as mean ± standard deviation (SD)
unless otherwise noted.

2.2 Results
Experiments were conducted on thirty-two piglets (17 females and 15 males),
divided into four cooling groups and one control group as described in Section 2.1.1, with
an average age of 47 ± 14 hours and an average weight of 2.7 ± 1.5kg. Table 2.1 presents
the summary of the physiologic parameters of the piglets (MAP, HR, paO2 and paCO2) in
Group I to IV and controls during cooling. All monitored physiological parameters
showed decreasing trends during cooling but only HR and MAP decreased significantly
(p<0.05) at the higher flow rate of 14-15 L.min-1 and lower temperature of -8 ± 2°C.
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Table 2.1. Physiological parameters measured at different times during SBC with different
methods.
Baseline
Cooling
1-60min
30 min
1 hr
36 ± 7
34 ± 6
36 ± 7
Control
40 ± 2
37± 1
35 ± 3
Group I: 3-4 L.min-1 at RT
MAP
33 ± 3
30 ± 2
28 ± 5
Group II: 3-4 L.min-1 at -1±2°C
(mmHg)
41 ± 4
39 ± 3*
36 ± 5*
Group III: 14-15 L.min-1 at RT
35 ± 7
32 ± 6*
30 ± 6*
Group IV: 14-15 L.min-1 at -8±2°C
162 ± 16
163 ± 15
162 ± 16
Control
139 ± 10
132 ± 9
128 ± 21
Group I: 3-4 L.min-1 at RT
-1
158 ± 16
154 ± 22
143 ± 25
HR (bpm) Group II: 3-4 L.min at -1±2°C
149 ± 15
135 ± 22*
125± 25*
Group III: 14-15 L.min-1 at RT
164 ± 15
145 ± 16*
133± 19*
Group IV: 14-15 L.min-1 at -8±2°C
39 ± 3
40 ± 3
39 ± 3
Control
40 ± 2
38 ± 2
39 ± 1
Group I: 3-4 L.min-1 at RT
paCO2
40 ± 2
39 ± 2
38 ± 4
Group II: 3-4 L.min-1 at -1±2°C
(mmHg)
-1
39 ± 2
39 ± 2
37 ± 1
Group III: 14-15 L.min at RT
40 ± 3
39 ± 2
38 ± 2
Group IV: 14-15 L.min-1 at -8±2°C
131 ± 44
133 ± 32
125 ± 30
Control
129 ± 19
99 ± 20
93 ± 14
Group I: 3-4 L.min-1 at RT
p aO 2
117 ± 15
110 ± 7
92 ± 13
Group II: 3-4 L.min-1 at -1±2°C
(mmHg)
103 ± 24
95 ± 19
94± 30
Group III: 14-15 L.min-1 at RT
-1
129 ± 3
111 ± 2
104 ± 2
Group IV: 14-15 L.min at -8±2°C
RT: Room Temperature; * a statistically significant (P<0.05) difference compared to the baseline.

Figure 2.3 displays the average cooling rates achieved with different
nasopharyngeal cooling methods and the brain temperature as a function of time for each
method. At the low flow rate of 3-4 L.min-1 mean brain cooling rate was significantly
greater (p<0.05) with -1 ± 2oC than room temperature air. Using either room temperature
or chilled air (-1 ± 2oC or -8 ± 2oC), there was statistically significant (P<0.05) greater
brain cooling rate with high (14-15 L.min-1) than low (3-4 L.min-1) flow rate. In the
control group, both rectal and brain temperature did not drop more than 0.5°C (brain: 0.35
± 0.3°C; rectal: 0.35 ± 0.3°C).
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(a)

(b)
Figure 2.3. (a) Mean brain cooling rate with different nasopharyngeal cooling methods; (b) Changes
in brain temperature over time for each method in Figure 2.3(a). * signifies a statistically significant
(P<0.05) difference between high flow rate versus low flow rate at both cold and room temperature; #
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signifies a statistically significant (P<0.05) difference between cold temp versus room temp at low
flow rate (3-4 L.min-1).

Following 60 minutes of baseline to demonstrate relatively constant brain (38.8 ±
0.2°C) and rectal (38.4 ± 0.2°C) temperature over this period, brain temperature started
falling immediately after the initiation of nasopharyngeal cooling with room temperature
air at a flow rate of 3-4 L.min-1. One hour post cooling, the brain and rectal temperatures
were 37.1 ± 0.9°C and 37.2 ± 0.5°C which resulted in mean brain cooling rates of 1.7 ±
0.9°C/h and 1.4 ± 0.9°C/h, respectively as displayed in Figure 2.4(a).

(a)
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(b)
Figure 2.4. Brain and rectal temperature over time for nasopharyngeal cooling method with (a)
room temperature and (b) -1 ± 2°C air at a flow rate of 3-4 L.min-1.

With the air flow rate at 3-4 L.min-1, the brain and rectal cooling rates were
increased by decreasing the air temperature to -1 ± 2°C by circulating cryogenic cooling
liquids in the outer tube of the double-walled pump tube. Figure 2.4(b) shows both brain
and rectal temperature decreased from 38.4 ± 0.7°C and 38.2 ± 0.7°C to 34.8 ± 1.7°C and
35.3 ± 1.7°C which corresponded to cooling rates of 2.6 ± 1.1°C/h and 1.8 ± 0.6°C/h,
respectively. Figure 2.4 shows that it was possible to maintain brain at the temperature
arrived at after an hour of cooling with a variation of 0.35 ± 0.45°C by decreasing the air
flow rate to 0.5-1.5 L.min-1. No significant differences were found between brain and
rectal cooling rates for either air temperature at the flow rate of 3-4 L.min-1. During the
baseline monitoring period, brain and rectal temperatures variations were the same (brain:
0.4 ± 0.4°C; rectal: 0.4 ± 0.5°C).
By increasing flow rate to 14-15 L∙min-1 at room temperature, Figure 2.5(a)
demonstrates that brain and rectal temperature could be reduced more rapidly at mean
rates of 4.3 ± 1.2°C/h and 3.7 ± 1.2°C/hr respectively. Mean brain temperature decreased
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to 33.7 ± 1.7°C within approximately 60 min of cooling from baseline (38.2 ± 1.1°C).
Figure 4.5(b) shows even greater cooling rate by using -8 ± 2°C air at the same flow rate.
Both brain and rectal temperature decreased from 38.4 ± 0.8°C and 38.1 ± 0.8°C to 32.8 ±
1.1°C and 35.1 ± 0.7°C which corresponded to a 5.5 ± 1.1°C/h and 3.2 ± 0.7°C/h,
respectively. At this higher air-flow rate of 14-15 L∙min-1, there were significant
differences between brain and rectal temperature during cooling for either room
temperature or -8 ± 2°C air. After cooling with room temperature or -8 ± 2°C air at a flow
rate of 14-15 L∙min-1 (but not with 3-4 L∙min-1), the rectal temperature continued to
decrease during the following 30 minutes when the air flow rate was decreased to 0.5-1.5
L.min-1 to maintain the brain temperature (Fig. 2.5 vs Fig. 2.4).

(a)
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(b)
Figure 2.5. Brain and rectal temperature over time for nasopharyngeal cooling method with (a)
room temperature and (b) -8 ± 2oC air at a flow rate of 14-15 L.min-1. * signifies a statistically
significant (P<0.05) difference between brain and rectal temperature.

Brain-body temperature gradient, calculated as the difference between brain and
rectal temperature, for room temperature or -8 ± 2°C air at the flow rate of 14-15 L∙min-1
over the baseline and the cooling period is shown in Figure 2.6. The temperature gradient
reached -1.75 ± 0.7°C after 20 minutes of cooling and remained significant (p<0.05)
during the rest of cooling period (Figure 2.6(b)).
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(a)

(b)
Figure 2.6. Changes in the brain-rectal temperature over time for intra-nasal cooling method with
setting the air flow rate to 14-15 L.min-1 at (a) room temperature and (b) cold temperature. * a
statistically significant (P<0.05) difference compared to the baseline.

Figure 2.7 (a) to (c) show H&E histopathological examination results of the frontal lobe
of the brain and nasal conchae (turbinates) from the nasal cavity of a piglet. There were
no pathological findings of bleeding, erythema and blister in the turbinates and of
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necrosis in the frontal lobe of brains in both gross and H&E histopathological
examinations.
(a)

500 µm

(c)

(b)

200 µm
Figure 2.7. Representative H&E histology shows (a) normal brain cells in grey and white matter of
the frontal lobe and (b) & (c) intact pseudostratified cilia and conchae (turbinates) cells in the nasal
cavity after the nasal cooling process.

2.3 Discussion
Hypothermia in the porcine brain can be achieved via three mechanisms: surface
cooling of superficial venous blood which in turn cools the arterial blood supply to the
brain; cooling of head skin, from which cooled venous blood in the scalp flows via
diploic and emissary veins to the brain (venous sinuses); and heat loss from the upper
airway.17-20 The latter two are thought to be mechanisms of SBC, i.e. lowering brain
temperature locally or as a whole below core trunk temperature.21 In particular, veins in
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the nasal mucosa of the upper airway drain into the cavernous sinus, a plexus (network)
of thin-walled veins, which closely intertwines with the carotid rete mirabile. Carotid rete
represents a vast vascular network at the base of the brain arising from branches of the
carotids before entering the circle of Willis. This intricate network comes into close
contact with the cavernous sinus which receives cool blood from the mucosa surfaces of
the nose. Furthermore, in species with carotid rete, it has been shown that blood flow in
the anglularis oculi vein (AOV), which is responsible for up 80% of SBC, increases with
low nasal temperature.22 In non-human species that do not have carotid rete, the large
surface of cavernous sinus, which is in close contact with the base of the brain, was
shown to provide the necessary heat exchanger and to make regional cooling of the brain
possible.23, 24
When the nasal cavity is cooled down as in our study, SBC is achieved via heat
exchange at the cavernous sinus between cold venous blood from nasal mucosa and warm
arterial blood in the carotid rete mirabile on route to the brain.25 Based on this heat
exchange method, we showed that SBC can be achieved by blowing -8 ± 2°C air at a flow
rate of 14-15 L∙min-1 into the nasal cavity: the brain temperature dropped from 38.1 ±
0.8°C to 32.8 ± 1.1°C in 60 minutes or a cooling rate of 5.5 ± 1.1°C/h while the body
temperature as measured by the rectal temperature probe was > 35oC during cooling.
Similarly, Covaciu et al., demonstrated the method of selectively cooling the brain
(≈3°C/h) with cold saline (8-10°C) circulating in balloon catheters placed into the nasal
cavities of large pigs.26 Likewise, Wolfson et al., employed transnasal evaporative
cooling system by spraying of perfluorocarbon liquid (perfluorohexane, PFH; F2
Chemicals) at room temperature which was driven by compressed oxygen into the nasal
cavities to achieve average intra-nasal brain cooling rate of ≈4°C/h in sheeps.27 The
influence of nasopharynheal cooling on brain temperature under different range of
circulatory states such as untreated cardiac arrest ("no-flow") or during normal circulation
("normal-flow") and cardiopulmonary arrest (CPR) situation ("low-flow") was also
shown in a porcine model in a study by Boller et al.28 Nasopharyngeal cooling device,
RhinoChill (BeneChill, Inc, SanDiego, Ca, USA), shows that the brain is preferentially
cooled compared with the other compartments of the body with a average cerebral
temperature decrease of -4.7°C for normal flow, -4.3°C for no flow and -3.4°C for low
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flow after 60 minutes.28 However, the brain-body temperature gradient was greatest in
"no-flow" group which was nearly 4°C, while the smallest gradient was 2°C during
normal blood flow.28 Intranasal cooling was beneficial even after prolonged cardiac arrest
in a porcine model, where it significantly improved the return of spontaneous
resuscitation (ROSC) rate and reduced CPR duration.29,

30

The administration of cold

nasal airflow and intranasal cooling were both tested in human studies.19,

31-34

These

methods proved to be feasible, safe and improved the neurological outcome. However,
evaluating the effect of selective cooling methods on the human brain is challenging
because direct measurements of the brain temperature cannot be made without the need
for surgery. Furthermore, invasive temperature measurements do not inform on the intracerebral distribution of temperature changes induced by these methods.
In humans, it was argued that the face and the surface of nasal mucosa as source
of cool venous blood are small in relation to the mass of the brain and the carotid rete,
where heat exchange might occur, does not exist.20 Moreover, a substantial fraction of the
blood supply to the brain is via the vertebral arteries, which have no direct contact with
cool venous blood. Because humans do not have a carotid rete, some have suggested that
there is no counter-current heat exchange in the cavernous sinus and, as a result, human
SBC is not possible. Yet the rete is not prerequisite for SBC because several other
mammals without carotid rete clearly demonstrate SBC.24,

35

Consequently, lack of a

carotid rete does not preclude the existence of SBC in humans or other mammals. The
internal carotid artery in humans is tightly surrounded by the venous plexus caroticus and
thereafter immersed in the cavernous sinus, and the vertebral arteries surrounded by a
plexus of veins where they course through the transverse foramina.20 The blood
temperature of the cavernous sinus decreases in response to chilled venous blood and
selectively cools the brain by means of heat exchange mechanism with the arterial blood.
Other components of the SBC system in humans are also thought to be cooling of head
skin via emissary and angular veins, CSF circulation and the upper respiratory tract.18, 36,
37

Mariak et al. directly demonstrated that increases or decreases in upper airway

ventilation gave proportional changes of intracranial temperatures supporting the
existence of this mechanism of brain cooling in human.33 Moreover, It has been shown
that the nasal mucosa blood flow increases 3-fold during hyperthermia conditions in
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humans and the cold venous blood flows via the angularis oculi vein to the brain, as in
other species.38, 39 A continuous and cold nasal airflow in patients was found to reduce
brain temperatures between 0.15-0.8°C.19,

33

Similarly, Dohi et al., achieved a lower

cooling rate of ≈2.5°C/h by blowing 24-26°C air at a flow rate of 8-12 L.min-1 directly
into the nasal cavities of two patients with Foley catheters adjunct with surface cooling.34
Recently, feasibility of preclinical transnasal evaporative cooling was successfully tested
in patients after cardiac arrest.31,

32

Castrén et al. demonstrated that the RhinoChill

intranasal cooling device was effective to reduce of tympanic temperature within the PreROSC Intranasal Cooling Effectiveness trial (PRINCE trial).32 This method was able to
show a significant decrease of tympanic temperature in the treatment group on arrival at
hospital (34.2°C versus 35.5°C). However, benefit towards survival and neurological
outcome was observed in the subgroup of cooling patients in whom CPR was initiated
within 10 minutes after collapse, although the design of the study was not conceived for
outcome analysis. In summary, prehospital treatment of patients with a cardiac cause of
the arrest may increase the rate of favorable outcome at hospital discharge.
The RhinoChill device vaporises perfluorchlorcarbon along with oxygen at flow
rate of 60-80 L.min-1 with a catheter system into the nasal cavity leading to a fast
induction of hypothermia first to the brain as main target organ and second to the body
with a slight delay.32 However, Perfluorocarbons raise environmental and health issues.
They are powerful greenhouse gases and deplete the ozone layer and are listed as toxic
substances under the Canadian Environmental Protection Act (CEPA).40 Another safety
concern is the risk of coolant aspiration which might cause lung damage over prolonged
periods since neural protection therapy may involve mild hypothermia being maintained
for a period of 72 hours.41 Therefore, new cooling methods should be effective in terms of
safety, fast cooling rates and easy to apply in the pre-clinical setting. We explored a
method of nasopharyngeal cooling by continuously blowing room temperature or
humidified cold air into the nostrils at different conditions on normal new-born piglets
with developed thermal regulation. Piglets were studied because they are commonly used
animal model of newborn human neurology.42 Thermoregulatory response in newborn
piglets were progressively achieved after 48 hours of birth.43 In our study, brain
temperature dropped with a mean cooling rate of 1.7 ± 0.9°C after the start of cooling
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procedure, by setting the air-flow rate to 3-4 L.min-1. The rate of brain cooling can be
improved by increasing the air-flow rate and/or decreasing the temperature of circulating
cryogenic cooling liquids in outer tube of heat exchanger. Brain temperature reduced
more rapidly at a rate of 5.6 ± 1.1°C/h with increasing air-flow to 14-15 L.min-1 at cold
temperature. Rectal temperature continued to drop till it reached to the brain temperature
during maintaining period. The decline in rectal temperature following the brain
temperature may be due to the balance between heat production in the rest of the body
and heat lost through cold air-flow in nasal cavities. Regardless of cooling conditions, HR
and MAP decreased with cooling. The level of gaseous carbon dioxide, or PaCO2, in
arterial blood depends on the solubility coefficient of this gas, which is dependent on
temperature and decreases as temperature decreases.44 The CO2 gas crosses the bloodbrain barrier and transmits the induced modifications (e.g., alkalosis in hypothermia)45 to
the extracellular environment, which regulates the state of arteriolar vascular tone. This
explains why hypothermia-induced hypocapnia may cause arteriolar vasoconstriction and
a decrease in intracranial pressure.14
Several factors could have influenced the possibility that the results in the
experimental studies could be reproduced in humans. Firstly, in all of the experimental
studies anaesthesia was maintained with Isoflurane. All general anaesthetics increase the
threshold for sweating and decrease the thresholds for vasoconstriction and shivering.46
Secondly, there are anatomical and physiological differences between new-born piglets
and humans that are important in this context. The baseline temperature in newborn
piglets and humans is different. Pigs differ considerably to humans in their ratio between
the size of their nasal cavity and their brain. Importantly, the newborn piglets, in contrast
to humans, have a carotid rete that may be a SBC system specific for the pig. Based on
the relatively rapid cooling rate achieved in this study by setting the air-flow rate to14-15
L.min-1, we suggest that nasal cooling with this technique still has great potential for
inducing hypothermia on large animal or human by increasing air-flow rate up to 60-80
L.min-1 at cold temperature. In conclusion, we have demonstrated that nasopharyngeal
cooling by spraying humidified and cooled air into nasal cavities is an effective, feasible
and simple method to selectively reduce and maintain brain temperature of newborn
piglets. This method can be easily implemented in hospitals and even on ambulances to
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cool down the brain to ameliorate brain damage from hypoxia-ischemia in newborns,
cardiac arrest in resuscitated patients, stroke and traumatic injury.

2.4 References
1.

Sadaka F, Veremakis C. Therapeutic hypothermia for the management of
intracranial hypertension in severe traumatic brain injury: A systematic review.
Brain Inj. 2012;26:899-908

2.

Quinn MW, Munyard PF. Treatment of asphyxiated newborns with moderate
hypothermia in routine clinical practice: How cooling is managed in the uk
outside a clinical trial. Arch Dis Child Fetal Neonatal Ed. 2010;95:F152

3.

Uray T, Haugk M, Sterz F, Arrich J, Richling N, Janata A, Holzer M, Behringer
W. Surface cooling for rapid induction of mild hypothermia after cardiac arrest:
Design determines efficacy. Acad Emerg Med. 2010;17:360-367

4.

Moore EM, Nichol AD, Bernard SA, Bellomo R. Therapeutic hypothermia:
Benefits, mechanisms and potential clinical applications in neurological, cardiac
and kidney injury. Injury. 2011;42:843-854

5.

Povlishock JT, Wei EP. Posthypothermic rewarming considerations following
traumatic brain injury. J Neurotrauma. 2009;26:333-340

6.

Guidelines for the management of severe traumatic brain injury. J Neurotrauma.
2007;24 Suppl 1:S1-106

7.

Mathur NB, Krishnamurthy S, Mishra TK. Evaluation of who classification of
hypothermia in sick extramural neonates as predictor of fatality. J Trop Pediatr.
2005;51:341-345

8.

Kuboyama K, Safar P, Radovsky A, Tisherman SA, Stezoski SW, Alexander H.
Delay in cooling negates the beneficial effect of mild resuscitative cerebral
hypothermia after cardiac arrest in dogs: A prospective, randomized study. Crit
Care Med. 1993;21:1348-1358

9.

Behringer W, Prueckner S, Safar P, Radovsky A, Kentner R, Stezoski SW,
Henchir J, Tisherman SA. Rapid induction of mild cerebral hypothermia by cold
aortic flush achieves normal recovery in a dog outcome model with 20-minute
exsanguination cardiac arrest. Acad Emerg Med. 2000;7:1341-1348

10.

Rogers MC, Greenberg M, Alpert JJ. Cold injury of the newborn. N Engl J Med.
1971;285:332-334

67
11.

Culic S. Cold injury syndrome and neurodevelopmental changes in survivors.
Arch Med Res. 2005;36:532-538

12.

Dudgeon DL, Randall PA, Hill RB, McAfee JG. Mild hypothermia: Its effect on
cardiac output and regional perfusion in the neonatal piglet. J Pediatr Surg.
1980;15:805-810

13.

Steen PA, Milde JH, Michenfelder JD. The detrimental effects of prolonged
hypothermia and rewarming in the dog. Anesthesiology. 1980;52:224-230

14.

Vigue B, Ract C, Zlotine N, Leblanc PE, Samii K, Bissonnette B. Relationship
between intracranial pressure, mild hypothermia and temperature-corrected paco2
in patients with traumatic brain injury. Intensive Care Med. 2000;26:722-728

15.

Benumof JL, Wahrenbrock EA. Dependency of hypoxic pulmonary
vasoconstriction on temperature. J Appl Physiol Respir Environ Exerc Physiol.
1977;42:56-58

16.

Bhatti MT. Orbital syndromes. Semin Neurol. 2007;27:269-287

17.

Baker MA. Brain cooling in endotherms in heat and exercise. Annu Rev Physiol.
1982;44:85-96

18.

Zenker W, Kubik S. Brain cooling in humans--anatomical considerations.
Anatomy and embryology. 1996;193:1-13

19.

Harris BA, Andrews PJ, Murray GD. Enhanced upper respiratory tract airflow and
head fanning reduce brain temperature in brain-injured, mechanically ventilated
patients: A randomized, crossover, factorial trial. Br J Anaesth. 2007;98:93-99

20.

Cabanac M. Selective brain cooling in humans: "Fancy" or fact? FASEB J.
1993;7:1143-1146; discussion 1146-1147

21.

Glossary of terms for thermal physiology. Second edition. Revised by the
commission for thermal physiology of the international union of physiological
sciences (iups thermal commission). Pflugers Arch. 1987;410:567-587

22.

Maloney SK, Mitchell G. Selective brain cooling: Role of angularis oculi vein and
nasal thermoreception. Am J Physiol. 1997;273:R1108-1116

23.

Fuller CA, Baker MA. Selective regulation of brain and body temperatures in the
squirrel monkey. Am J Physiol. 1983;245:R293-297

24.

Caputa M, Kadziela W, Narebski J. Significance of cranial circulation for the
brain homeothermia in rabbits. Ii. The role of the cranial venous lakes in the
defence against hyperthermia. Acta Neurobiol Exp (Wars). 1976;36:625-637

68
25.

Gillan LA. Blood supply to brains of ungulates with and without a rete mirabile
caroticum. J Comp Neurol. 1974;153:275-290

26.

Covaciu L, Allers M, Enblad P, Lunderquist A, Wieloch T, Rubertsson S.
Intranasal selective brain cooling in pigs. Resuscitation. 2008;76:83-88

27.

Wolfson MR, Malone DJ, Wu J, Hoffman J, Rozenberg A, Shaffer TH, Barbut D.
Intranasal perfluorochemical spray for preferential brain cooling in sheep.
Neurocritical care. 2008;8:437-447

28.

Boller M, Lampe JW, Katz JM, Barbut D, Becker LB. Feasibility of intra-arrest
hypothermia induction: A novel nasopharyngeal approach achieves preferential
brain cooling. Resuscitation. 2010;81:1025-1030

29.

Tsai MS, Barbut D, Wang H, Guan J, Sun S, Inderbitzen B, Weil MH, Tang W.
Intra-arrest rapid head cooling improves postresuscitation myocardial function in
comparison with delayed postresuscitation surface cooling. Crit Care Med.
2008;36:S434-439

30.

Wang H, Barbut D, Tsai MS, Sun S, Weil MH, Tang W. Intra-arrest selective
brain cooling improves success of resuscitation in a porcine model of prolonged
cardiac arrest. Resuscitation. 2010;81:617-621

31.

Busch HJ, Eichwede F, Fodisch M, Taccone FS, Wobker G, Schwab T, Hopf HB,
Tonner P, Hachimi-Idrissi S, Martens P, Fritz H, Bode C, Vincent JL, Inderbitzen
B, Barbut D, Sterz F, Janata A. Safety and feasibility of nasopharyngeal
evaporative cooling in the emergency department setting in survivors of cardiac
arrest. Resuscitation. 2010;81:943-949

32.

Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D,
Eichwede F, Mols P, Schwab T, Vergnion M, Storm C, Pesenti A, Pachl J,
Guerisse F, Elste T, Roessler M, Fritz H, Durnez P, Busch HJ, Inderbitzen B,
Barbut D. Intra-arrest transnasal evaporative cooling: A randomized, prehospital,
multicenter study (prince: Pre-rosc intranasal cooling effectiveness). Circulation.
2010;122:729-736

33.

Mariak Z, White MD, Lewko J, Lyson T, Piekarski P. Direct cooling of the
human brain by heat loss from the upper respiratory tract. J Appl Physiol (1985).
1999;87:1609-1613

34.

Dohi K, Jimbo H, Abe T, Aruga T. Positive selective brain cooling method: A
novel, simple, and selective nasopharyngeal brain cooling method. Acta Neurochir
Suppl. 2006;96:409-412

69
35.

McConaghy FF, Hales JR, Rose RJ, Hodgson DR. Selective brain cooling in the
horse during exercise and environmental heat stress. J Appl Physiol (1985).
1995;79:1849-1854

36.

Nagasaka T, Brinnel H, Hales JR, Ogawa T. Selective brain cooling in
hyperthermia: The mechanisms and medical implications. Med Hypotheses.
1998;50:203-211

37.

White MD, Greiner JG, McDonald PL. Point: Humans do demonstrate selective
brain cooling during hyperthermia. J Appl Physiol (1985). 2011;110:569-571;
discussion 581-562

38.

Caputa M, Perrin G, Cabanac M. [reversal of human ophthalmic vein blood flow :
Selective cooling of the brain]. C R Acad Sci Hebd Seances Acad Sci D.
1978;287:1011-1014

39.

White MD, Cabanac M. Nasal mucosal vasodilatation in response to passive
hyperthermia in humans. Eur J Appl Physiol Occup Physiol. 1995;70:207-212

40.

Chemicals Management Division of Environment Canada. List of toxic substances
managed under cepa (schedule 1), available at: Http://www.Ec.Gc.Ca/toxiquestoxics/default.Asp?Lang=en&n=98e80cc6-1&xml=aa329670-c3c7-4ad5-a7ab5fd8a05439f1. (20 April 2012).

41.

Azzopardi D, Strohm B, Edwards AD, Halliday H, Juszczak E, Levene M,
Thoresen M, Whitelaw A, Brocklehurst P, Steering G, participants TCR.
Treatment of asphyxiated newborns with moderate hypothermia in routine clinical
practice: How cooling is managed in the uk outside a clinical trial. Arch Dis Child
Fetal Neonatal Ed. 2009;94:F260-264

42.

Roohey T, Raju TN, Moustogiannis AN. Animal models for the study of perinatal
hypoxic-ischemic encephalopathy: A critical analysis. Early Hum Dev.
1997;47:115-146

43.

Herpin P. Development of thermoregulation and neonatal survival in pigs.
Livestock Production Science. 2002;78:25-45

44.

Tremey B, Vigue B. [changes in blood gases with temperature: Implications for
clinical practice]. Ann Fr Anesth Reanim. 2004;23:474-481

45.

Ream AK, Reitz BA, Silverberg G. Temperature correction of pco2 and ph in
estimating acid-base status: An example of the emperor's new clothes?
Anesthesiology. 1982;56:41-44

46.

Sessler DI. Mild perioperative hypothermia. N Engl J Med. 1997;336:1730-1737

70

71

Chapter 3
Monitoring Brain Temperature by Time-Resolved
Near-Infrared Spectroscopy: A Pilot Study
This chapter is adapted from the work entitled “Monitoring Brain Temperature by TimeResolved Near-Infrared Spectroscopy” by M Fazel Bakhsheshi, M Diop, K St. Lawrance
and TY Lee, submitted to the Journal of Bio-Medical Optics. The focus of this paper is to
investigate the potential of time-resolved near-infrared spectroscopy (TR-NIRS) to
measure absolute temperature in tissue-mimicking phantoms (in-vitro) and deep brain
tissue temperature (in-vivo).

3.

Introduction
Clinical studies have shown that hypothermia improves neurological outcome and

reduces mortality following cardiac arrest, traumatic brain injury, birth asphyxia and
ischemic encephalopathy.1-3 Despite its well-documented efficacy, the widespread
application of hypothermia in neuro-emergencies has been hampered by the difficulty of
noninvasively monitoring brain temperature. As well, cooling the whole body below 3334°C can induce severe complications including, sclerema, skin erythema, renal failure,
coagulopathy, pulmonary hypertension, and even death.4 SBC methods, such as using a
cooling helmet or nasopharyngeal cooling, have been proposed to alleviate the
complications associated with systemic hypothermia by directly cooling the brain while
maintaining body temperature to as close to normal as possible.5 However, SBC requires
a method that can measure local brain temperature rather than body temperature as the
latter may not reflect the actual brain temperature.
Several approaches have been developed to assess brain temperature. Local brain
temperature can be measured invasively by inserting a thermometer directly into the brain
parenchyma, which provides accurate measurements but carries a significant risk of
complications. Infrared tympanic thermometer is noninvasive; however, it does not
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provide continuous monitoring and is sensitive to positioning errors. 6,

7

Magnetic

resonance spectroscopy (MRS) can be used to measure brain temperature8, but its clinical
utility is hampered by a long measurement time and by the need to transfer patients to
imaging facilities. Brain temperature measurement techniques have also been developed
using other modalities such as ultrasound9, microwave radiometry10 and the zero-heatflux technique.11 However, these techniques suffer from practical issues such as inducing
temperature increase, and poor temporal and spatial resolution.
Optical methods are a promising alterative to the aforementioned techniques since
they are safe and the instruments are compact and portable. As well, temperaturedependent changes in water absorption spectra have been well characterized by nearinfrared spectroscopy (NIRS).12 The water absorption peaks around 740, 840 and 970 nm
shift to shorter wavelengths and increase in intensity with increasing temperature12-14, due
to decreases in the extent of intermolecular hydrogen bonding among water molecules
with increasing temperature. In fact, NIRS thermometry approaches based on broadband
continuous wavelengths (CW) and diffuse correlation spectroscopy (DOS) have been
developed to predict deep tissue temperature in an adult forearm and breast,
respectively.12, 15 Chung et al. used the water peak at 970 nm to predict temperature in
tissue mimicking phantoms and breast tissue.15 Using this water peak to monitor brain
temperature is challenging because of the strong water absorption at this wavelength
which limits depth penetration. In this study, the temperature-dependency of the water
absorption peaks at ~740 nm and ~840 nm was investigated as an alternative approach for
monitoring brain temperature. Although the temperature changes at these features are not
as great as at 970 nm, this is compensated by the high water concentration in the brain,
80-90% in the newborn brain.16 TR-NIRS was used in order to separate the effects of
tissue scattering from absorption and to provide better depth sensitivity.17 The method
was validated in tissue-mimicking phantoms by correlating TR-NIRS temperature
calculations to simultaneous thermometer measurements, and was subsequently used to
monitor brain temperature in newborn piglets during cooling. Deep brain temperature was
also measured continuously with a thermocouple probe.
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3.1 Materials and Methods
3.1.1 Instrumentation
The light sources of the TR-NIRS system consisted of thermoelectrically cooled
picosecond pulsed diode lasers (LDH-P-C, PicoQuant, Germany) emitting at 760, 810
and 830 nm and a computer controlled laser driver (SEPIA PDL 828, PicoQuant,
Germany). These emission wavelengths were chosen to quantify tissue chromophores
(oxy-hemoglobin, HbO2 and deoxy-hemoglobin, Hb)18 and characterize temperaturedependent changes of the water absorption peaks. The lasers’ output power and pulse
repetition rate were set to 1.4 mW and ~27 MHz, respectively. The individual pulses of
the three lasers were temporally separated by sharing the 80 MHz clock of the laser
drivers. Light emitted by each diode laser was attenuated by two adjustable neutral
density filters (NDC-50-4M, Thorlabs, Newton, NJ) and coupled by a microscope
objective lens (NA = 0.25, magnification = 10x) into one arm of a trifurcated fiber bundle
(three fibers; NA = 0.22, core 400 m, Fiber Optics Technology, Pomfret, Connecticut).
The distal common end of the bundle (emission probe) was placed on the surface of the
phantom (or scalp of the piglets) and held in position by a probe holder. The average
power delivered to a subject was attenuated to ~20 W per laser, which is below ANSI
safety limits for skin exposure.19
Photons emerging from the phantom (piglet scalp) were collected by a 2-m fiber
optic bundle (NA = 0.55, 3.6 mm diameter active area, and 4.7-mm outer diameter, Fiber
Optics Technology). The other end of the detection probe was secured in front of an
electromechanical shutter (SM05, Thorlabs). Light transmitted through the shutter was
collected by a Peltier cooled microchannel plate photomultiplier tube (MCP-PMT) (PMC100, Becker and Hickl, Germany). Detection of a photon generated an electrical pulse
(amplitude of 50-200 mV, width = 1.5 ns) that was transmitted to a time-correlated single
photon counting (TCSPC) module (SPC-134, Becker and Hickl, Germany) to build the
temporal point spread function (TPSF).
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3.1.2 Optical Properties Measurement
To quantify tissue optical properties (i.e., the absorption coefficient μa and the
reduced scattering coefficient μs′) from the measured TPSFs, the instrument response
function (IRF) was measured to account for dispersion by the system.20 The IRF was
acquired by placing a thin piece of white paper between the emission fiber and the
detection fiber bundle. The paper was coated with black toner to reduce specular
reflection.21 IRFs were measured at the start and end of each experiment at the same
count rate as the TPSFs (~800 kHz). Measurement of the optical properties was obtained
using an analytical model of light diffusion.22 The model solution was first convolved
with the measured IRF, and then a nonlinear optimization routine (MATLAB function
fminsearch) was used to fit the convolved model to each measured TPSF to determine
optical properties (μa and μs′) and scaling factor which accounts for laser power, any
potential drift in the intensity of light source, detection gain, and coupling efficiency.20
The fitting range was set to 80% of the peak value on the leading edge and 20% on the
falling edge.23 The TPSFs measured at baseline (i.e., before initiation of cooling) were
averaged and fitted to extract the baseline optical properties as well as the scaling factor.
Thereafter, changes in light absorption caused by cooling were characterized by using μ a
as the only fitting parameter; μs′ and the scaling factor were set to their baseline values to
improve the stability of the fitting procedure and reduce errors causing by cross-talk
between fitting parameters i.e., μa-μs′.12, 20 However, temperature effects on the reduced
scattering coefficients, presented in Table 3.1 and 3.3, determined using only the scaling
factor as the fix parameter. Tissue optical properties at each temperature were determined
from averaging of 32 TPSFs collected at a sampling interval of 10 s (i.e., 320 s). The
maximum count rate was set to 1% of the laser repetition rate (800 kHz), to minimize
pile-up effect.24 However, Diop et al. showed that the error resulting from distortions in
TPSF shape was relatively small by measuring the IRF at the two extremes count rate
(400 and 800 kHz).25 Finally, the measured changes in μa were used to calculate changes
in temperature, as discussed in detail in the section 3.2.
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3.1.3 Tissue mimicking Phantom Experiments
Tissue-mimicking phantoms (N = 7), composed of solutions of 95% distilled
water, 0.8% intralipid and 4.2% whole piglet blood, were used for comparison of TRNIRS temperature calculations and thermometer measurements. Each solution together
with a (magnetic) stirrer were placed in a Pyrex beaker on a heating and stirring plate.
The emission and detector probes of the TR-NIRS instrument were positioned on the
surface of the solution at a source-detector distance of 2 cm. A thermometer (VWR
digital thermometer with 0.1°C precision, VWR International Inc) was also placed in the
solution for concomitant TR-NIRS and temperature measurements. The phantom
(solution) was stirred before each measurement to ensure homogeneity of both optical
properties and temperature. Each experiment was completed within 3 hours during which
the sample temperature was raised from ~32 to 38°C. The phantom and its container were
weighed prior to heating, and again at the end of the experiment; the average total weight
loss during the whole experiment was approximately 0.5 ± 0.3%.

3.1.4 Animal Preparation and Experimental Procedure
In-vivo experiments were conducted on eight piglets (6 females and 2 males)
whose average age and weight were 1.6 ± 0.7 days and 1.9 ± 0.4 kg, respectively. Animal
experiments were approved by the Animal Use Subcommittee of the Canadian Council on
Animal Care at Western University and conducted according to its guidelines. Newborn
Duroc cross piglets were obtained from a local supplier on the morning of the experiment.
Piglets were anesthetized with 1-2% isoflurane (3-4% during preparatory surgery). A
tracheotomy was performed and the piglet was ventilated with a volume-controlled
mechanical ventilator to deliver oxygen and medical air mixture (2:1). A femoral artery
was catheterized to monitor heart rate (HR) and mean arterial blood pressure (MAP), and
to intermittently collect arterial blood samples for gas analysis and measure of blood
glucose levels. Deep brain temperature was also measured continuously with a
thermocouple probe; a burr hole was drilled in the skull with a Dremal tool and a needle
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thermocouple probe was inserted laterally through the skull into the brain to a depth of 2
cm vertical from the brain surface and 1.5 cm posterior to the bregma along the mid-line.
After surgery, a heated water blanket was used to maintain rectal temperature between
37.5-38.5°C. Normocapnia (37-40 mmHg) was maintained throughout the experiment by
adjusting the breathing rate and volume, depending on the arterial CO2 tension (pCO2)
obtained from the blood samples or from monitoring end-tidal CO2 tension. Arterial
oxygen tension (paO2) was maintained at a level between 90-130 mmHg by adjusting the
ratio of oxygen to medical air at ventilator setting. Blood glucose was also monitored and
1-2 ml infusion of 25% glucose solution was administered intravenously if blood glucose
concentration fell below 4.5 mmol/L.
The experiment started at a delay of 60 min after the completion of the surgical
procedures to allow time for the physiological variables (HR, MAP, pCO2 and paO2) to
stabilize. This delay was also sufficient to minimize any drift artifacts in the TR-NIRS
measurements.26 Piglets were placed in the prone position and a custom-made probe
holder was strapped to the head to hold the emission and detection probes 2 cm apart,
parasagittally, approximately 1.5 cm dorsal to the eyes directly in front of thermometer
probe. Temperature was altered by placing plastic ice bags on the surface of the piglet’s
body until the brain temperature decreased to 31-32°C over ~ 3 to 4 hours. For each
experiment, the baseline count rate measured with the TR instrument was adjusted to 800
kHz to match the count rate used to measure the IRF and was fixed for the remaining of
the study. Tissue absorption coefficients were determined from reflectance data acquired
continuously for 320 s at intervals of 10 s each. The entire experiment was completed
within 5 hours. After the last measurement, the animals were sacrificed with intravenous
potassium chloride (1-2 ml/kg) infusion. Thereafter, the brain was harvested and placed in
paraformaldehyde (PFA) for 24 to 48 hours, and then transferred into a phosphate buffer
saline (PBS) solution for preservation. Excised brains were later paraffin-embedded and
cut into 5 µm-thick serial sections to verify the position of temperature probe and assess
any potential bleeding caused by inserting the probe.
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3.2 Data Analysis
A number of approaches have been developed to characterize the temperature
dependence of the water absorption spectrum, including Gaussian component, classical
and inverse least-squares, hybrid method and principal components analysis (PCA).12 In
this study, TR-NIRS data were analyzed with PCA method to predict tissue temperature.
It has been shown that PCA can reduce random errors compared to the other methods and
improve the fitting to the model.12

3.2.1 Temperature Fitting Algorithm
The workflow to predict the temperature was as follows:
(i)

Hollis et al. described the calibration of pure water absorption spectrum

against temperature as a combination of components, known as principal
components, that vary linearly with temperature.12 As a first step, a data set (X)
containing many independent variables was decomposed into two sets of linear
variables. In matrix notation, principal component regression (PCR) can be
described as follows:
X=S.P,

(3-1)

where the rows of data matrix X (n×m) are the (n) pure water absorption spectra
over (m) wavelengths at different temperatures at 0.1°C steps between 25°C and
45°C used in the calibration. The rows of P (h×m) are the principal components of
X, S (n×h) contains the components scores and (h) is the number of principal
component used in the model. A MATLAB program was written to determine the
principal components of the mean-centered data using an eigenvector
decomposition technique.27 It has been shown that the first PC accounted for 99%
of the total variance of the calibration absorption spectra.12 The next stage of the
PCR calibration was to establish a linear relationship between the components
scores and temperature.12 The model is defined as follows:
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t=S.v,

(3-2)

where t is the vector of the known calibration temperatures, v is the calibration
vector relating the scores to the temperature. Equations (3-1) and (3-2) provide the
principal components (matrix P) and calibration vector (v) that are used to predict
the temperature from any spectrum.12
(ii)

The extinction coefficients of the major chromophores (H2O, HbO2 and

Hb) were used to recover their concentrations from the absorption coefficients
measured at the three wavelengths by TR-NIRS. Since the pure water absorption
spectra were mean-centered for the PCR calibration, the mean water absorption
coefficients from the calibration must also include to the fitting. Although the
mean calibration coefficients could also be subtracted (rather than fitted to) from
the measured tissue absorption coefficients:
,

(3-3)

where µa(λ) is the absorption coefficient measured at wavelength λ, ci is the
concentration of the ith chromophore, ɛi(λ) is the extinction coefficient at λ,
is the the mean pure water absorption coefficient from the calibration at
λ, Si is the score of the ith loading vector, and Pi(λ) is a loading vector of the pure
water at λ. In the first step, a least-square optimization algorithm (MATLAB
function fminsearchbnd28) was used to extract the score of one pure water loading
vector, i.e. PC, and concentrations of oxy- and deoxy-hemoglobin at baseline
temperature by assuming a known water concentration of 95% and 85% for
phantom and tissue experiments, respectively.16,

29

The optimization function is

bound constrained, where bounds were applied to the recovered values to limits of
search for oxy- and deoxy-hemoglobin concentrations to be in the range of 30-60
µM30 and 5-25 µM31,

32

, respectively. Note, the extinction coefficients of pure

water as a function of temperature, oxy- and deoxy-hemoglobin used in this study
were taken from literature.33, 34
(iii)

Predicted temperature was calculated by multiplying the scores of water
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loading vectors found in the previous step by the calibration vector:
,

(3-4)

where v is the calibration vector relating the scores to the temperature obtained in
step (i).
(iv)

If the initial predicted temperature was different from the known

temperature obtained by the thermometer at the beginning of the experiment, the
Equation (3-3) from step (ii) was altered to include a constant in order to find the
corrected score related to the pure water loading vector corresponding to the initial
temperature.

(3-5)
,
(v)

The magnitude of the constant was determined using an iterative algorithm

based on the criterion:
,

(3-6)

where
(3-7)
(vi)

For subsequent temperature predictions, the chromophore fitting was

repeated with the constant obtained from the correction for initial temperature, and
then tissue temperature was computed as described in step (iii).

3.3 Statistical Analysis
SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses.
Normality of the distribution of the measurements was verified using Kolmogorov–
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Smirnov test. Physiological parameters between different temperatures were then
analyzed using one-way ANOVA. Correlations between the predicted temperatures
against the temperatures measured by thermometry were analyzed using parametric linear
regression. Finally, the degree of similarity between temperature measurements acquired
with the two techniques was evaluated using a Bland-Altman plot.35 Comparisons of
optical properties (μa and μs′) at different temperatures were analyzed by a repeatedmeasures two-way mixed ANOVA to determine statistical differences as a function of
temperature for different wavelengths. Statistical significance was based on p-value <
0.05. All data are presented as mean ± SD unless otherwise noted.

3.4 Results
Table 3.1 displays the temperature effects on absorption and reduced scattering
coefficients for the tissue-mimicking phantom. There was a statistically significant
increase in absorption coefficient when temperature increases above 36°C at all three
wavelengths. The absorption coefficients were significantly lower at 760 nm than at 810
and 830 nm while the reduced scattering coefficients were significantly higher at 760 nm
than at 830 nm. No significant differences were found for reduced scattering coefficients
between temperatures.
Table 3.1. Absorption and reduced scattering coefficients measured at three discrete wavelengths
as function of temperature in in-vitro (tissue-mimicking phantoms). Values are mean  SD.
Variable λ (nm)
(38°C)
(36°C)
(34°C)
(32°C)
830
0.0175 ± 0.007*†
0.0152 ± 0.006† 0.0147 ± 0.005† 0.0142 ± 0.005†
810
0.0155 ± 0.005*†
0.0134 ± 0.005† 0.0131 ± 0.005† 0.0127 ± 0.004†
μa (mm-1)
*
760
0.0118 ± 0.003
0.0103 ± 0.003 0.0101 ± 0.003
0.0099 ± 0.003
830
1.97 ± 0.19†
1.97 ± 0.15†
1.99 ± 0.14†
1.99 ± 0.12†
-1
2.06 ± 0.26
2.06 ± 0.21
2.05 ± 0.21
2.08 ± 0.20
μs′ (mm ) 810
760
2.17 ± 0.22
2.16 ± 0.17
2.21 ± 0.21
2.21 ± 0.19
* a statistically significant (P<0.05) difference compared to the baseline (32°C). † a statistically
significant (P<0.05) difference compared to wavelength of 760 nm.

Figure 3.1 shows the measured against predicted temperature of the tissuemimicking phantoms. The average slope, intercept and R2 value from the individual
regression analyses were 1.01, -0.16°C, 0.82. From the Bland-Altman analysis in Figure
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3.1(b), the mean difference between the predicted and measured temperatures was 0.1°C.
The 95% confidence interval of the difference between the two were 2.3°C to -2.1°C.

(a)

(b)
Figure 3.1: (a) Correlation plot comparing temperature in the tissue-mimicking phantom calculated
using data acquired by TR-NIRS against temperature measured with a thermometer (labeled
Predicted Temperature and Measured Temperature, respectively). Each symbol type represents
data from one of seven experiments with the tissue-mimicking phantom. The solid line represents the
average of all individual linear regression lines and the dotted line indicates the line of identity (slope
=1). (b) Bland-Altman plot comparing Predicted and Measured temperature. The dotted line shows
the mean difference and dash-dotted lines show the limits of agreement (mean±2 SD) between the
two temperature measurements.
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Table 3.2 provides a summary of the measured physiological parameters in piglets
at the different brain temperatures. There was a statistically significant decrease in HR
and PaO2 when temperature dropped to 34°C and lower. Analysis of the brain tissue
sections revealed no gross hemorrhages caused by insertion of the thermometer probe into
the brain.
Table 3.2. Physiological parameters measured at different brain temperatures. Values are mean 
SD.
(38°C)
(36°C)
(34°C)
(32°C)
MAP (mmHg)
42 ± 5
41 ± 4
40 ± 4
38 ± 4
HR (bpm)
139 ± 10
125 ± 14
109 ± 11*
94 ± 13*
pH
7.4 ± 0.01
7.4 ± 0.02
7.4 ± 0.01
7.5 ± 0.1
paCO2 (mmHg)
39 ± 1
38 ± 2
40 ± 1
38 ± 1
paO2 (mmHg)
122 ± 15
93 ± 7
90 ± 17*
75 ± 17*
Hb (µmol/L)
24.9 ± 9.2
25.4 ± 10.8
25.2 ± 11.2
26.7 ± 11.1
HbO2 (µmol/L)
63.4 ± 20.9
62.9 ± 20.6
63.3 ± 19.9
61.5 ± 20.2
tHb (µmol/L)
88.4 ± 22.3
88.3 ± 23.1
88.7 ± 22
88.9 ± 21.8
MAP=mean arterial blood pressure; HR=heart rate; tHb=total hemoglobin; Hb=Deoxy-hemoglobin;
HbO2=Oxy-hemoglobin. * a statistically significant (P<0.05) difference compared to the baseline
(38°C).

Table 3.3 provides the measured μa and μs′ in the piglet brain at three wavelengths
and at different temperatures. The absorption coefficient was higher at 830 nm than at
810 and 760 nm and, as expected, the reduced scattering coefficient decreased as
wavelength increased.36
Table 3.3. Absorption and reduced scattering coefficients measured at three discrete wavelengths
as function of temperature in in-vivo (newborn piglets brain). Values are mean  SD.
Variable
λ (nm)
(38°C)
(36°C)
(34°C)
(32°C)
830
0.0240 ± 0.005† 0.0242 ± 0.005† 0.0225 ± 0.005† 0.0177 ± 0.001
810
0.0214 ± 0.003
0.0219 ± 0.004 0.0204 ± 0.003
0.0168 ± 0.002
μa (mm-1)
760
0.0214 ± 0.002
0.0223 ± 0.003 0.0212 ± 0.004
0.0173 ± 0.002
830
0.68 ± 0.08†
0.67 ± 0.07†
0.67 ± 008†
0.67 ± 0.05†
-1
810
0.74 ± 0.10
0.74 ± 0.08
0.73 ± 0.11
0.80 ± 0.05
μs′ (mm )
760
0.79 ± 0.13
0.78 ± 0.11
0.73 ± 0.13
0.81 ± 0.12
†
a statistically significant (P<0.05) difference compared to wavelength of 760 nm.

Figure 3.2(a) shows a correlation plot comparing predicted brain temperature
calculated using data acquired from TR-NIRS against temperature measured with a
thermometer. Results from regression analysis for each piglet, as well as the average of
all experiments are shown in Figure 3.2(a). From the Bland-Altman analysis in Figure
3.2(b), the mean difference between the predicted and measured temperatures was 0.5°C.
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The 95% confidence interval of the difference between the two were 2.7°C to -3.6°C. The
average slope, intercept and R2 value from the individual regression analyses were 1.1, 1.6°C, 0.66, respectively.

(a)

(b)

Figure 3.2: (a) Correlation plot comparing temperature in the piglet brain calculated using data
acquired by TR-NIRS against temperature measured with a thermometer (labeled Predicted
Temperature and Measured Temperature, respectively). Each symbol type represents data from one
of eight piglets. The solid line represents the average of all individual linear regression lines and the
dotted line indicates the line of identity (slope =1). (b) Bland-Altman plot comparing Predicted and
Measured temperature. The dotted line shows the mean difference and dash-dotted lines show the
limits of agreement (mean ± 2SD) between the two temperature measurements.
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3.5 Discussion
We investigated the ability of TR-NIRS technique to measure temperature in
tissue-mimicking phantoms and newborn piglet’s brains using the temperaturedependence of water absorption features around ~740 nm and ~840 nm during heating
and cooling, respectively. The TR-NIRS temperature measurements in this study were
based on subtle changes in the NIR water absorption characteristics due to macromolecular binding with the following assumptions. First, the concentration of water in the
brain is assumed 85% in order to calculate the score of one pure water loading vector, i.e.,
one PC as well as cerebral hemoglobin concentrations. Second, the initial tissue
temperature is known from thermometer to find the corrected score related to the pure
water loading vector corresponding to this temperature. Third, to determine optical
properties from changes in light absorption caused by cooling, the scaling factor and μs′
were set to the values determined from the baseline measurements and only μa was
included as fitting parameter. This approach has been shown to improved the stability of
the fitting procedure by limiting the number of fitting parameters as well as reducing
cross-talk between parameters.12, 20 For example, including scaling factor or μs′ as a fitting
parameter along μa resulted in a weak correlation of R2 = 0.68 and R2 = 0.57 between the
TR-NIRS method and thermometer measurements for phantom experiments, respectively
(data not shown). Furthermore, in our calculation, we assumed that the molar extinction
coefficient of oxy- and deoxy- hemoglobin are constant over the temperature range of 3931°C. However, temperature-dependent changes of the hemoglobin NIR absorption
spectra have been investigated37; it has been shown that with increasing temperature in
the range of 20-40°C the amplitude of Hb and HbO2 decreased by 0.15-0.18% °C-1 and by
less than 0.05% °C-1 and shifted by 0.08 nm °C-1 and 0.15 nm °C-1, respectively.37
The proposed method for calculating temperature were tested against direct
thermometer measurement in tissue-mimicking phantom. Results demonstrate that TRNIRS was sensitive to temperature changes via changes in tissue water absorption
coefficient and could measure the temperature of the tissue-mimicking phantom. A strong
correlation (R2 = 0.82) of the predicted temperature calculated using TR-NIRS data to the
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measured temperature with a thermometer was observed, with a slope of 1.01 indicating
the equivalency between the optical and thermometer measurements over the temperature
range of 33-38°C. The average difference between the TR-NIRS predicted temperature
and the measured temperature was 0.15 ± 1.1°C.
For the in-vivo temperature measurement we used piglets because they are
commonly used animal model of human newborn neurology38 and signal contamination
from the minimal extra-cerebral tissue is relatively negligible, which enables the
measured TPSFs to be modeled as the solution of the diffusion equation for a
homogeneous semi-infinite geometry.25 A correlation between the thermometer measured
and TR-NIRS predicted temperature was obtained (R2 = 0.66) with a slope of 1.1 over the
temperature range of 39-31°C. There are thermoregulatory responses to a decline in body
temperature, such as the effects of cold-induced vasoconstriction, reduction of mean
arterial pressure and cardiac output.39 Vasoconstriction decreases the vascular space
during hypothermia40, which decrease the volume of blood in the region probed by the
TR-NIR light, and hence a reduction in μa. Moreover, the red blood cells are known to be
a source of light scattering in tissue and typically occupies less than 2% of brain
volume41, therefore a greater values of μs′ observed in in tissue-mimicking phantom
compared with the piglet brain may be explained by higher concentration, i.e. ~4%, of
whole blood used in solution.
There are a number of potential sources of error that could contribute to the
discrepancy between the TR-NIRS predicted and thermometer measured temperature.
One source of error is employing the pure water absorption spectrum and parameters
associated with the temperature response that were used for fitting tissue temperature i.e.,
calibration vector and PCs. The difference in absorption spectrum between tissue and
pure water is due to bound water within tissue.42 However, in our calculation, the
chromophore fitting was performed with the loading vectors obtained from the PCR of
the pure water absorption spectrum rather than that of ‘tissue water’, which resulted in the
predicted temperature either underestimating or overestimating the thermometer
temperature. A correction was performed using a constant value according to equation (33) to make the predicted temperature as close as possible to the true initial temperature,
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which was known from the thermometer. We also note that temperature prediction was
not improved by the inclusion of more than one water loading vector, i.e. more PCs (only
one was used in this study). Another potential source of error could be due to error in the
determination of dispersion caused by the TR system (i.e. IRF of the system)25. In general
the accuracy of the temperature prediction by our NIRS technique can be improved by
having a continuous tissue absorption spectrum which offers better chromophore
identification and improved concentration measurement of major tissue chromophores,
i.e., water , oxy-, deox- hemoglobin and fat, particularly for water peak at 970 nm due to
its greater temperature sensitivity and lower scattering in tissue. This can be done by
combination of TR and CW spectroscopy, whereas most of the wavelength coverage is
provided by a white-light CW measurement, and the TR data are acquired at a few
selected NIR wavelengths. Measuring several μs′ values can be used in a simple function
of wavelength to obtain estimates of μs′ across the entire wavelength range.43 With μs′
calculated and the measured CW reflectance, coefficients of absorption will be derived
from the diffusion equation at all wavelengths in the spectral window of interest. 44
Another possible way to improve the reproducibility of the predicted tissue temperature
by the NIRS technique would be to perform multiple measurements (predictions) at each
temperature and calculate the average of the predicted temperatures. The major challenge
in adapting this technique to adult patients is the significant signal contamination from
superficial tissues. This is not a concern in neonatal applications, where the scalp and
skull is negligible and it is reasonable to assume that all the collected light has traveled
through brain tissue. However, in the adult subjects, the scalp, skull, and cerebral spinal
fluid surrounding the brain can contribute significantly to absorption. In this case, it
becomes very difficult to measure absolute concentrations of cerebral chromophores. It
has previously been demonstrated that the depth sensitivity of the NIR signal is
proportional to the distance separating emitter and detector45. This multi-distance, or
depth-resolved approach allows the separation of information into superficial and deep
components on the basis that light penetration increases with source-detector distance.
Consequently, by collecting information at multiple distances simultaneously, it is
possible to separate out information in terms of tissue layers, using an optical
reconstruction approach.46
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In conclusion, we have demonstrated a method of monitoring tissue temperature
non-invasively using the temperature response of water absorption peaks in the NIR
spectral region. The results from tissue-mimicking phantoms show a strong correlation
(R2 = 0.82) between the TR-NIRS method and thermometer measurements and we
showed the potential of TR-NIRS method to measure temperature in-vivo in an animal
model of the newborn. Since NIRS is safe and measurements can be obtained at the
bedside in only a few minutes, it is believed that this technique could assist in monitoring
of brain temperature in the neonatal intensive care unit during hypothermia therapy.
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Chapter 4
Coupling of Cerebral Blood Flow and Oxygen
Consumption during Hypothermia under
Different Anesthetics in Newborn Piglets
Measured by TR-NIRS
This chapter is adapted from the work entitled “Coupling of Cerebral Blood Flow and
Oxygen Consumption During Hypothermia Under Different Anesthetics in Newborn
Piglets Measured with a Time-Resolved Near-Infrared Technique”, submitted to the
Biomedical Optics Express by: M Fazel Bakhsheshi, M Diop, K St. Lawrance and TY
Lee. The focus of this paper is two-fold: to investigate the sensitivity of the TR-NIR
technique to measure CBF during cooling at different temperatures, for validation, CBF
was independently measured by CT perfusion at each temperature; and, to investigate the
cerebral metabolic activity during hypothermia under different anesthetics.

4.

Introduction
Mild hypothermia (HT), in which the brain temperature is lowerd to 32-33°C, has

been shown to be an effective neuoprotective therapy to reduce brain injury following
cardiac arrest, traumatic brain injury and birth asphyxia and ischemic encephalopathy.1
One of the important mechanisms of HT-induced neuroprotection is the preservation of
brain ATP levels resulting from a reduction in cerebral metabolism or metabolic rate of
oxygen (i.e. CMRO2).2 The effects of HT on CBF are a consequence of the well-accepted
phenomenon that CMRO2 is closely coupled to CBF and therefore, a reduction in the
former is coupled to a reduction in the latter.3, 4 Preserving the coupling between CBF and
CMRO2 is an important factor in the control of the cerebral circulation, connecting the
change in metabolic demands with the supply of substrates by blood flow. As a
consequence of this balance between flow and metabolism, the oxygen extraction fraction
(OEF) indicates any regional variation in brain. For example under oxidative stress, e.g.
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ischemia-hypoxia, the OEF is increased from its basal value of ~30% leading to cerebral
venous desaturation.5-7
Clinically, HT is typically induced under anesthesia to minimize brain damage, so
it is important to determine whether the combination of anesthesia and HT alters flowmetabolism coupling or deviates OEF from its basal values. Current methods to monitor
changes in energy metabolism using PET and blood flow using MRI or CT are hampered
by practical issues such as need to transfer patients to imaging facilities and prolonged
scanning times, both of which are not practical for unstable patients. Therefore, a noninvasive method that can be available over prolonged periods of cooling and rewarming
phases is required since neural protection therapy may involve HT being maintained for
periods of 72 hours.8,

9

Optical methods are promising alternatives to these current

techniques since they are safe, the instruments are compact, portable and can provide
physiological measurements at the bedside of patients. We have previously developed a
dynamic contrast-enhanced NIR technique for measuring absolute CBF and CMRO2
based on the Fick's Principle using a light-absorbing dye, indocyanine green (ICG), as an
intravascular contrast agent.10,

11

12

However, there has been no previous study

investigating feasibility of using time-resolved (TR) NIR technique to measure CBF and
CMRO2 during HT. The purpose of the current study is two-fold:
(i). Validate the TR-NIR CBF measurement against that measured using a CT
perfusion technique at different temperatures during HT13;
(ii). Investigate the coupling of CMRO2 and CBF under HT and different anesthetic
combinations that may be used in clinical practice.
In the present study, CBF and CMRO2 were measured with a TR-NIR technique in
newborn piglets in which brain temperature was lowered from ~38° to 33°C under three
anesthetic regimes: isoflurane, propofol/nitrous oxide (N2O) and propofol/35-50% xenon
(Xe35-50%). The latter regime (propofol/Xe35-50%) was used in the combined therapy of HT
and Xe for neuroprotection in neurointensive care units (NICU) 14; increasing
neuroprotection from ~35% with HT32°C only to ~70% when HT32°C was combined with
50% inhaled Xe gas.15 Although recent study has shown that neonates with (Hypoxic-
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Ischemic Encephalopathy) HIE undergoing HT have low CBF and CMRO2 when
compared with healthy age-matched neonates16, there is no study examine the effect of
HT on OEF alternations or flow-metabolism coupling under different anesthetic regimes
and temperatures. Understanding how the combination of HT under different anesthetic
may alter flow-metabolism coupling or deviates OEF from its basal values in the healthy
brain is critical before extending these neuroprotective strategies to the injured brain.

4.1 Materials and Methods
4.1.1 Instrumentation
The light sources of the TR-NIR system are thermoelectrically cooled picosecond
pulsed diode lasers (LDH-P-C emitting at 760, 810 and 830 nm, PicoQuant, Germany)
activated by a computer controlled laser driver (SEPIA PDL 828, PicoQuant, Germany).
The 760 and 830nm emission wavelengths were chosen to quantify tissue chromophores
(oxy-hemoglobin, HbO2 and deoxy-hemoglobin, Hb) which were used to determine the
cerebral oxygen saturation, while 810 nm laser coincides with the peak absorption
wavelength of ICG in plasma. The output power and pulse repetition rate of the lasers
were set to 1.4 mW and ~27 MHz, respectively. The individual pulses of the lasers were
temporally separated by sharing the 80 MHz clock of the laser driver among the three
lasers. Light emitted by each diode laser was attenuated by two adjustable neutral density
filters (NDC-50-4M, Thorlabs, Newton, NJ) and coupled by a microscope objective lens
(NA=0.25, magnification=10x) into one arm of a trifurcated fiber bundle (three fibers;
NA=0.22, core 400 m, Fiber Optics Technology, Pomfret, Connecticut). The distal
common end of the bundle (emission probe) was placed on the scalp of the animal and
held in position by a probe holder. The average power delivered to a subject was
attenuated to ~20 W per laser, which is below ANSI safety limits for skin exposure.17
Photons emerging from the scalp were collected by a 2-m fiber optic bundle
(NA=0.55, 3.6 mm diameter active area, and 4.7-mm outer diameter, Fiberoptics
Technology). The other end of the detection probe was secured in front of an
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electromechanical shutter (SM05, Thorlabs). Light transmitted through the shutter was
collected by a Peltier cooled microchannel plate photomultiplier tube (MCP-PMT) (PMC100, Becker and Hickl, Germany). Detection of single photons generated electrical pulses
(amplitude of 50-200 mV, width=1.5 ns) that were transmitted to a time-correlated single
photon counting (TCSPC) module (SPC-134, Becker and Hickl, Germany) to generate
the temporal point spread function (TPSF). As described in detail elsewhere11, tissue
optical properties (i.e., the absorption coefficient μa and the reduced scattering coefficient
μs′) were obtained using analytical solution of light diffusion to model the collected
TPSFs .

4.1.2 Determination of Cerebral Blood Flow
CBF was measured using a bolus-tracking method that requires an intravenous
bolus injection of ICG (1 ml, 0.2 mg/kg) into a peripheral vein, followed by continuous
measurements of the time-varying concentrations of the dye in arterial blood and brain
tissue. The arterial concentration, Ca(t), was measured non-invasively by a dye
densitometer (model DDG-2001 A/K, Nihon Kohden, Tokyo, Japan) with the probe
attached to a front foot. Brain tissue concentration, Cicg(t), was determined from
reflectance data acquired by the TR-NIRS instrument continually for 76s at a sampling
interval of 400 ms. The two concentration curves are related by the following equation:
(4-1)

where * represents the convolution operator and [CBF.R(t)] is the flow-scaled impulse
residue function or R(t). The function CBF·R(t) can be extracted from the arterial and
tissue ICG concentration curves using a deconvolution algorithm13. The initial height of
the derived function is CBF, since by definition R(0)=1, and the area under the curve is
the cerebral blood volume (CBV).18 For the TR-NIR data, quantification of the brain
concentration of ICG was determined from the measured change in μa11:

96
(4-2)
where μa(0) represents the baseline value determined over a 10-second period prior to an
injection of ICG, and ICG is the extinction coefficient of ICG at 810 nm.

4.1.3 Determination of cerebral metabolic rate of Oxygen
Measurements of CMRO2 were calculated10 using Fick's principle as follows:

(4-3)

The difference between the arterial concentration of oxygen, [O2]a, and the cerebral
venous concentration of oxygen, [O2]v, is commonly referred to as the arterial-venous
difference of oxygen (AVDO2), or the difference between the O2 concentration of the
arterial blood feeding the tissue of interest and O2 concentration of the venous blood
draining the tissue of interest. Equation (4-3) can be further expanded as follows19:
(4-4)

where

] is total hemoglobin concentration which can be measured from arterial

blood samples.

are arterial and venous O2 saturation, respectively. The

constant 1.39 is the O2 carrying capacity of hemoglobin measured in milliliters per gram
of Hb. Note that the dye densitometer also provides continuous measurements of
while

,

was determined indirectly from TR-NIRS measurements of average tissue

cerebral blood oxygen saturation,

. This technique relies on the assumption

that there exists a stable arterial-venous blood ratio in the CBV, i.e.
(4-5)
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where

represents the fraction of arterial blood in CBV. The relative distribution of

arterial and venous compartments is generally accepted to be approximately 25% and
75% in the total CBV, therefore to measure

was set to 0.25.20, 21 To obtain tissue

cerebral blood oxygen saturation, i.e.,

, cerebral hemoglobin (HbO2, Hb)

concentrations were calculated with TR-NIRS which relies on the assumption that there is
stable concentration of water in the brain , i.e., ~85%22. These hemoglobin measurements
were determined by fitting the tissue absorption coefficients to the extinction coefficients
of the major chromophores, i.e., (water, Hb, HbO2). Tissue absorption coefficients were
determined from reflectance data acquired continuously for 160s (i.e. 32 TPSFs) at a
sampling interval of 5s.

can then be calculated as follows:

(4-6)

Using this relationship, a new expression for
of

can be derived that is independent

:

(4-7)

The fraction of oxygen extracted from arterial blood into the brain, OEF, was calculated
with the method described by Brown et al10:

(4-8)

The tight coupling of CBF and CMRO2 in the normal brain leads to a fixed level of OEF
around ~33%.23 A decoupling of the two, signifies oxidative stress, as in ischemia, and
would lead to an increase in OEF beyond the normal value of ~33%.6
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4.1.4 Animal Preparation and Experimental Procedure and Groups
Experiments were conducted on fifteen newborn piglets. All animal experiments
were approved by the Animal Use Subcommittee of the Canadian Council on Animal
Care at our institution. Newborn Duroc cross piglets were obtained from a local supplier
on the morning of the experiment. Anesthesia was induced with 1-2% isoflurane which
was increased to 3-4% during preparatory surgery. A tracheotomy was performed and the
piglet was ventilated with oxygen and medical air mixture. A femoral artery was
catheterized to monitor HR and MAP and to intermittently collect arterial blood samples
for gas (paCO2, paO2), pH and glucose concentration analysis. A cannula was inserted into
an ear vein for infusion of Propofol (AstraZeneca Pharmaceuticals, Canada Inc) and ICG
(Sigma-Aldrich, Saint Louis, Missouri). After surgery, piglets were maintained on 1-2%
isoflurane at normothermia (NT37°C). Arterial CO2 tension (paCO2) was monitored
throughout the experiment, either directly by blood gas measurements or by the end-tidal
CO2 tension, and maintained at normocapnia between 37-40 mmHg by adjusting the
breathing rate and ventilation volume. Arterial oxygen tension (paO2) was maintained at a
level between 90-130 mmHg by adjusting the ratio of oxygen to medical air. Blood
glucose was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of
25% dextrose solution was administered intravenously. Deep brain temperature was also
measured with a thermocouple probe. The needle thermocouple probe was inserted
laterally into the brain to a depth of 2 cm vertical from the brain surface and 0.5 cm
posterior to the bregma. Animals were placed in a prone position and a custom-made
probe holder was strapped to the head to hold the TR-NIRS emission and detection
probes 2 cm apart, parasagittally, approximately 1.5 cm dorsal to the eyes. The
experiments started after a delay of 60 min to allow time for the animals to stabilize
following surgery. This delay was also sufficient for the TR-NIR instrument to reach a
quasi-equilibrium to minimize drift artifacts in TR-NIR measurements due to temperature
changes.24 Piglets were randomized into three groups:
(i). Group I (N=7) had baseline (normothermia) CT and TR-NIR CBF measurements
in the following order: one CT CBF scan, two TR-NIR CBF measurements
separated by 10min before and after CT measurements. Following the baseline

99
(normothermia)

CBF

measurements,

TR-NIR

followed

by

CT

CBF

measurements were collected at ~2°C decrement from the baseline temperature
of 38° to 32°C under isoflurane anesthesia; and,
(ii). Group II (N=4) had two TR-NIRS measurements of CBF and CMRO2 under
inhalational isoflurane (1-2%) anesthesia first and then both measurements were
repeated under intravenous infusion of Propofol (9-22.4 mg/kg/h) and ventilation
with 70% nitrous oxide (N2O

70%)

and 30% oxygen (O2

30%)

while brain

temperature was changed from normo- (38°C) to hypo-thermia (35° and 33°C);
and,
(iii). Group III (N=3) was the same as Group II except that nitrous oxide and oxygen
mixture was replaced by xenon/oxygen/nitrogen mixture (Xe
10-20%

35-50%,

O2 30-40%, N2

respectively) using the closed-circuit Xe/O2 delivery system.25

For propofol (10mg/ml) infusion, the rate was adjusted according to their responses, and
change in vital signs such as blood pressure, and pain responsiveness of the piglet. The
mean infusion rates were 2.51 ± 1.15 and 2.95 ± 1.11 ml/hr during propofol/N2O (Group
II) and propofol/Xe (Group III) anesthesia, respectively. For normothermia, a heated
water blanket was used to maintain rectal and brain temperature between 38°-38.5°C. For
induction of HT, brain temperature was altered by exposing the piglet’s body to room
temperature. For each anesthetic regime, two measurements of CBF and CMRO 2 were
collected per brain temperature. Each experiment was completed within 5 hours. After the
last measurement, the animals were sacrificed with intravenous potassium chloride (1-2
ml/kg) infusion.

4.1.5 Computed Tomography Measurement
For Group I piglets, they were placed in a light speed 64-slice CT scanner (GE
Healthcare, Waukesha, WI, U.S.A), the mobile TR-NIR apparatus was brought to the CT
scanner and all TR-NIR measurements were obtained while the piglets remained in a
prone position on the scanner table. Each CT CBF measurement began with a scout CT
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scan to choose the locations of the CT slices to coincide with the position of the NIR
optodes. To measure CBF, each piglet received a 1.0-mL/kg injection of the iodinated
contrast agent iohexol (300 mg I /mL; Omnipaque™, GE Healthcare, Waukesha,
Wisconsin), at a rate of 1.0 mL/s into the umbilical vein. Sequential (dynamic) CT scans
were acquired using 80 kVp, 190 mA with the scanner once every second, for a period of
40s. Each scan provided eight contiguous 5 mm thick coronal slices with a 12 cm field of
view set to encompass the entire head and front legs of the piglet in a prone position. CBF
map were generated from the serial image sets using CT Perfusion3 software (General
Electric Healthcare). This package is based on the same deconvolution routine used to
calculate CBF with the NIRS data and has been validated in our laboratory against the
gold standard microsphere CBF measurement.13 Regions of interest (ROIs) manually
drawn using an in-house developed in the IDL Development Environment (ITT Visual
Information Solutions, Boulder, Colorado) program on the CT perfusion images that
corresponded to the brain volume interrogated by the TR-NIR probes and mean CBF
within the regions were averaged before comparison with the TR-NIR CBF. The ROIs
only included the top ~1.5 cm of brain to account for the depth sensitivity of NIRS.

4.1.6 Statistical Analysis
SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses.
Normality of the distribution of the measurements was verified using KolmogorovSmirnov (KS) test. Comparisons between temperature-based measurements within groups
were performed by a repeated-measures one-way ANOVA when the variables were
normally distributed (Group I) or, if the normality test failed, by the Friedman test
(Groups II-III). Wilcoxon test was used to determine statistical differences when the
anesthetic was switched from isoflurane to propofol/N2O (Group II) and propofol/Xe
(Group III). Correlations between CT and NIRS CBF in Group I were analyzed using
parametric linear regression. Statistical significance was based on p-value < 0.05. All data
are presented as mean ± SD unless otherwise noted.
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4.2 Results
Experiments were conducted on fifteen newborn piglets (9 females and 6 males),
with an average age of 35 ± 12 hours old and an average weight of 1.7 ± 0.2kg. Due to
difficulties to maintain normocapnia condition throughout the experiment, data from two
piglets in Group I was excluded from analysis. Table 4.1 presents a summary of the
averaged physiologic parameters of the piglets (MAP, HR, paCO2, paO2, pH, SaO2 and
OEF) in the three groups, according to anesthetics used and brain temperature. In group I,
there was a statistically significant decrease in HR and PaO2 (p<0.05) compared to
baseline (normothermia) when temperature reached below 35°C. The heart rate dropped
slowly with the induction of HT from 139 ± 10 to 94 ± 13 over the whole temperature
range (38-32°C). In group II, when the anesthetic was switched from isoflurane to
Propofol/N2O, there was a statistically significant increase in HR and MAP (p<0.05)
compared to baseline (isoflurane); but HR started decreasing immediately after the
initiation of cooling and return to baseline (isoflurane) level when temperature fell to
35°C and a statistically significant decrease in paO2 when temperature fell below 35°C
with the Propofol/N2O combination of anesthetics (p<0.05). No significant paCO2, SaO2,
OEF or pH differences were found among different anesthetics and among different
temperatures.
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Table 4.1. Physiological parameters measured at different groups.
Baseline
Cooling
Variable
(38°C)
(38°C)
(35°C)
(32°C)
Baseline / Cooling
Group I (isoflurane / isoflurane)
42 ± 5
42 ± 5
40 ± 4
38 ± 4
MAP
Group II (isoflurane / propofol/N2O)
42 ± 4
56 ± 6*
52 ± 2*
50 ± 11*
(mmHg)
Group III (isoflurane / propofol/Xe)
42 ± 5
45 ± 10
36
33
Group I (isoflurane / isoflurane)
139 ± 10
139 ± 10
117 ± 11*
94 ± 13*
HR
Group II (isoflurane / propofol/N2O)
148 ± 5
226 ± 41*
195 ± 8*
138 ± 28
(bpm)
Group III (isoflurane / propofol/Xe)
148 ± 7
168 ± 26
100
84
Group I (isoflurane / isoflurane)
39 ± 1
39 ± 1
41 ± 1
38 ± 1
paCO2
Group II (isoflurane / propofol/N2O)
40 ± 2
41 ± 2
41 ± 1
40 ± 2
(mmHg)
Group III (isoflurane / propofol/Xe)
39 ± 2
41± 4
40
43
Group I (isoflurane / isoflurane)
122 ± 15
122 ± 15
95 ± 17*
75 ± 17*
paO2
Group II (isoflurane / propofol/N2O)
155 ± 40
210 ± 49
136 ± 4*
85 ± 16*
(mmHg)
Group III (isoflurane / propofol/Xe)
164 ± 49
140 ± 43
101
89
Group I (isoflurane / isoflurane)
7.4 ± 0.02
7.4 ± 0.02
7.4 ± 0.03
7.4 ±0.04
pH
Group II (isoflurane / propofol/N2O)
7.4 ± 0.06
7.4 ± 0.06
7.3 ± 0.09
7.3 ± 0.13
Group III (isoflurane / propofol/Xe)
7.4 ± 0.04
7.4 ± 0.03
7.46
7.42
Group II (isoflurane / propofol/N2O)
100
97 ± 2
98 ± 1
97 ± 1
SaO2 (%)
Group III (isoflurane / propofol/Xe)
100
99 ± 1
99
100
Group II (isoflurane / propofol/N2O)
0.11 ± 0.01 0.11 ± 0.02 0.11 ± 0.02 0.11 ± 0.01
[O2]a
Group III (isoflurane / propofol/Xe)
0.12 ± 0.01 0.11 ± 0.01
0.11
0.11
MAP=mean arterial blood pressure; HR=heart rate; [O2] a=arterial concentration of oxygen, *significantly
(p<0.05) different from baseline.

Figure 4.1(a) is a coronal CT image of a piglet showing the holder and the
positions of the two TR-NIR probes (white arrows). Figure 4.1(b-e) show coronal CBF
maps at different temperatures and ROIs enclosing a ellipse-shaped trajectory that light
travel from the source to the detector in each case.

Figure 4.1. (a) Coronal CT image showing the location of the TR-NIR probes and the ROIs enclosing
a ellipse-shaped trajectory that light travel from the source to the detector. (b-e) Corresponding CBF
maps at 38° (normothermia), 36°, 34° and 32°C. The region of interest used to measure CBF from the
CBF map in each case is also shown.

Figure 4.2 shows that decreasing the brain temperature in Group I piglets (N=7)
resulted in a decrease in TR-NIR CBF from 54.3 ± 5.4 to 33.8 ± 0.9 ml.min-1.100g-1 and a
decrease in CT CBF from 56.8 ± 2.5 to 41.9 ± 2.1 ml.min-1.100g-1 at 38° and 32°C,
respectively.
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Figure 4.2. TR-NIR and CT CBF measurements in piglets (N=7) plotted as a function of brain
temperature (N=7).

A correlation plot comparing CT and TR-NIR CBF and the corresponding BlandAltman plot are shown in Figure 4.3 The average slope, intercept and R2 value from the
individual regression analyses were 1.3, -19 ml.min-1.100g-1, and 0.84 respectively. From
the Bland-Altman analysis, the mean difference between the two methods was 5.84
ml.min-1.100g-1. The 95% confidence limits of the difference between the two methods
were from -15.3 to 27 ml.min-1.100g-1.
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(a)

(b)

Figure 4.3. (a) Correlation plot comparing CT and the TR-NIR CBF. The solid line represents the
average of all individual linear regression (slope = 1.3 and intercept = -19 ml.min-1.100g-1). (b)
Bland-Altman plot of CT and TR-NIR CBF. The dotted line shows the mean difference and dashdotted lines show the limits of agreement (mean ± 2 SD).

Figure 4.4(a) displays TR-NIR CBF and CMRO2 measurements in Group II
piglets (N=4) under two different anesthetic regimes (i.e., isoflurane only and
propofol/N2O mixture) at three different brain temperatures. Both CBF and CMRO2
values decreased from 50.42 ± 8.7 to 31.07 ± 8.7 ml.min-1.100g-1 and 2.46 ± 0.6 to 1.5 ±
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0.4 mlO2.min-1.100g-1 at normothermia (38°C) when the anesthetic was switched from
isoflurane to propofol/N2O and both decreased from 31.07 ± 8.7 to 23.9 ± 5.9 ml.min1

.100g-1 and 1.5 ± 0.4 to 1.1 ± 0.01 mlO2.min-1.100g-1 in HT when brain temperature

decreased from 38° to 33°C under propofol/N2O anesthesia. The OEF values under the
different anesthetics and brain temperatures employed in group II, was plotted in Figure
4.4(b). It shows that both HT and different anesthetics (i.e. isoflurane and propofol/N2O)
did not deviate OEF from its basal values which expressing tight coupling of CBF to
CMRO2; any change in metabolic demand were met by a corresponding change in
substrate delivery via CBF modulation.

(a)
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(b)
Figure 4.4. (a) Cerebral blood flow (CBF) and oxygen metabolic rate (CMRO 2); and (b) Oxygen
extraction fraction (OEF) in Group II piglets (N=4) at each cerebral temperature under isoflurane
or propofol/N2O anesthetic regimes. Values are shown as mean ± SD; * p<0.05 versus at 38°C with
isoflurane.

Figure 4.5(a) displays TR-NIR CBF and CMRO2 measurements in Group III
piglets (N=3) under isoflurane and then propofol/Xe anesthesia at three different
temperatures (only one piglet was cooled down to 33°C). Both CBF and CMRO2 values
decreased from 49.4 ± 14.2 to 34.9 ± 12.1 ml.min-1.100g-1 and 2.3 ± 0.7 to 1.4 ± 0.53
mlO2.min-1.100g-1 at normothermia (38°C) when the anesthetic was switched from
isoflurane to propofol/Xe and decreased under propofol/Xe anesthesia from 34.9 ± 12.08
to 23.6 ml.min-1.100g-1 and from 1.44 ± 0.53 to 1.05 mlO2.min-1.100g-1 respectively
when brain temperature decreased from ~38° to 33°C. Similarly, Figure 4.5(b) shows that
OEF remains unchanged under isoflurane anesthesia and under propofol/Xe anesthesia at
different temperatures.
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(a)

(b)
Figure 4.5. (a) Cerebral blood flow (CBF) and oxygen metabolic rate (CMRO 2), (b) Oxygen
extraction fraction (OEF) in Group III piglets (N=3) at each cerebral temperature under isoflurane
or propofol/Xe anesthetic regimes. Values are shown as mean ± SD; * p<0.05 versus at 38°C with
isoflurane.
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4.3 Discussion
In the present study TR-NIR CBF measurements were validated against CT CBF
measurements in a neonatal animal model in which brain temperature was lowered from
38° to 32°C under isoflurane anesthesia. Our results revealed a linear correlation between
two CBF measurement techniques, but the TR-NIR technique underestimated CBF
measured with CT. There are a number of factors that can explain this discrepancy. One
source of error is incorrectly characterizing the amount of dispersion caused by the TR
system (i.e., variations between the measured and true instrument response function
(IRF)).11 Additionally, this study used CT perfusion to validate the CBF which required
selecting ROIs underneath the NIRS probe that corresponded to the area interrogated by
the NIR light. The error in the CBF measurements caused by variable ROI selection can
also explain the differences between two techniques. Another explanation is that the
method to recovered optical properties is based on the diffusion approximation with the
assumption that the light is propagating in a homogeneous semi-infinite geometry which
is less true for the newborn model since the head size is significantly smaller than the
adult.26 It has been shown that the model approximation can lead to errors in the
recovered optical properties by 20% at short source-detector distances (5-20mm).26 In
addition, the relatively thin layer of superficial tissues on the newborn head compromised
of skin, muscle, and skull, could have an effect on the NIR signal and the accuracy of
CBF measured with TR-NIR technique.26, 27 Although it becomes dominant in the adult
case because of the larger thickness of the scalp and skull.23,28 Previous studies have
reported that CBF collected using NIRS approaches can be underestimated by more than
a factor of 3, due primarily to the increase in optical path length through extracerebral
tissue.29
Furthermore, we examined the relationship between CMRO2 and CBF under
normothermia (38°C) or mild whole-body HT (35° or 32°C) with different anesthetics ,
isoflurane(1-2%)/(N2 66%, O2 33%), propofol/(N2O 70%, O2 30%) or propofol/(Xe 35-50%, O2 3040%,

N2 10-25%) which are representative of what may be used in clinical practice.14, 30 Our

results showed that mild HT decreases both CBF and CMRO2 compared to normthermia
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with preserved flow-metabolism coupling and constant OEF under different anesthetics.
Flow-metabolism coupling within brain is a complex physiologic process that is regulated
by a combination of metabolic, glial, neural, and vascular factors.31-33 In the normal brain,
CBF is regulated by autoregulation, cerebrovascular and metabolic reactivity induced by
changes in arterial carbon dioxide tension to maintain a tight coupling between CBF and
CMRO2. However, during cerebral ischemic insults, alterations of cerebral hemodynamic
and metabolism are highly dynamic. As cerebral perfusion pressure (CPP) falls, CBF is
maintained by vasodilatation of resistance arterioles, known as autoregulation.34 When
the capacity for compensatory vasodilatation has been exceeded, autoregulation fails and
CBF falls as a function of pressure. When oxygen supply is diminished due to decreasing
CBF, OEF increases in an effort to compensate for the reduced CBF and maintain a stable
CMRO2 to preserve neuronal function and cellular integrity.33 If the CPP continues to
fall, CBF will progressively decline until the increase in OEF is no longer sufficient to
supply the oxygen to meet metabolic demand which causes to reduce CMRO2. Energy
failure will result and permanent tissue damage may develop. Therefore, deviation of
OEF from its basal value may be a more specific marker to monitor for oxidative stress
from whatever causes that can lead to cerebral dysfunction.
The vasodilating effects of isoflurane have limited its use as a sedative agent in
the NICU because of the fear of a potential increase in intracranial pressure (ICP) caused
by the increase in CBF.35 However, propofol is being used more frequently in the
neurosurgical intensive care unit, particularly for head-injury cases.36 Propofol is known
to decrease CBF while preserving brain flow-metabolism coupling and act as a global
central nervous system depressant.35 It has been shown that a typical anesthetic induction
dose of propofol reduces blood pressure by approximately 30% resulting from a decrease
in sympathetic activity, direct vasodilation, and myocardial depression.37,

38

When the

anesthetic was switched from isoflurane to propofol, there was a statistically significant
increase in HR, suggesting that decrease in peripheral vascular resistance induced by
propofol was partially compensated by an increase in heart rate.35 The use of a
background propofol infusion with Xe and N2O is due to the fact that both anesthetic
cannot induce reliable anesthesia on their own.
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Although quantitative and mobile, a limitation with the TR-NIR technique is the
need to inject a bolus of ICG every time CBF is measured. However, this is a minimally
invasive procedure since ICG is injected into a peripheral vein and the arterial ICG timeconcentration curve can be measured noninvasively by pulse dye densitometry.
Moreover, Verdecchia et al have shown that TR-NIR can be combined with diffuse
correlation spectroscopy (DCS) to provide almost ‘continuous’ quantitative assessment of
CBF and CMRO2.39 DCS is used to measure changes in CBF and CMRO2 from their
values at baseline (or calibration) which, in turn, are measured using TR-NIR with ICG
injection as discussed in this report. With this approach, only infrequent injections of ICG
is needed to calibrate the pseudo-continuous measurement of changes into absolute values
of CBF and CMRO2. Piglets were studied because signal contamination from extracerebral tissue is relatively low, which enables the measured TPSFs to be characterized
by the diffusion equation for a homogeneous semi-infinite geometry.
In conclusion, we have shown the ability of TR-NIR technique to measure
absolute CBF during HT and investigated the cerebral metabolic activity under different
anesthetics at different temperature in a normoxia animal model. Both CBF and CMRO2
decreased by decreasing the temperature but the OEF remained unchanged which
indicates a tight coupling of flow and metabolism under different anesthetics over the
mild HT temperature range (38°-33°C) which might not be the case in the ischemic brain.
Furthermore, rewarming is a critical phase of therapeutic HT to monitor for oxidative
stress.9, 40 Rapid rewarming of the injured brain commonly leads to a mismatch between
cerebral metabolism and perfusion9 and can cause in rebound intracranial pressure
elevations41, cerebral venous desaturation40, and brain ischemia. It is suggested that
controlling the rewarming rate as low as 0.1-0.4°C/hour is preferred to reduce the
neurological risks.42 Therefore, predicting and managing possible systemic side effects of
rewarming is also important for guaranteeing HT efficacy. As the next step, we will be
investigating the OEF changes before, during and after HT in hypoxic-ischemic neonatal
pigs.
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Chapter 5
Conclusions and Future Work
5.

Summary of Stated Objectives
The introduction chapter of this thesis discussed the importance of selective brain

cooling to maximize the neuroprotictive effects of mild hypothermia and avoid adverse
complications from whole body cooling. The primary objective of this research, therefore,
was to develop a nasopharyngeal cooling approach which targets only the brain tissue not
only capable of inducing fast cooling but also can maintain the target temperature over
extended period of time (Chapter 2). However, a proper evaluation of brain cooling
requires accurate measurement of the brain temperature locally instead of relying on
inference from core temperature. For this purpose, a non-invasive technique was
developed to measure brain temperature during hypothermia as described in Chapter 3.
As discussed in detail in the previous chapters, one of the important mechanisms of
hypothermia-induced neuroprotection is due to suppression of brain metabolism, and it is
important to determine whether the combination of anesthesia and hypothermia alters
flow-metabolism coupling. In Chapter 4, we examined the effect of hypothermia on flowmetabolism coupling under different anesthetic regimes and temperatures.
The next section of this chapter will summarized each of these developments
within the context of the objectives presented in Chapter 1. Following this, future
directions of this research will be discussed.
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5.1 Whole-Body and Selective Brain Cooling Approach
(i)

Selective Brain Cooling Using Nasopharyngeal Method
Cooling the nasopharynx may offer the capability to cool the brain selectively by

cooling inflowing blood in both internal carotid arteries (ICAs) via counter-current heat
exchange mechanism with the neighboring cavernous sinuses which collect cold venous
blood from the mucosal linings of the nasal cavities. Furthermore, cerebrospinal fluid
chilled at the basal cistern cools the whole brain through the cerebrospinal fluid (CSF)
circulation. We have demonstrated an effective, safe and simple method of
nasopharyngeal cooling by continuously blowing room temperature or humidified cold air
at different flow rates into the nostrils of normal new-born piglets with developed thermal
regulation (Chapter 2). Effective brain cooling in new-born piglets was achieved with a
median cooling rate of 1.7 ± 0.9°C/h by setting the flow rate of room temperature air to 34 L.min-1. Results of comparing different temperatures and flow rates in the
nasopharyngeal cooling approach reveal that the brain temperature could be reduced
rapidly at a rate of 5.6 ± 1.1°C/h by increasing air flow rate to 14-15 L.min-1 while
keeping air at a cold temperature (≈-8°C). It was also possible to maintain brain
temperature within ± 0.45°C for an hour once it reached the target temperature of 3334oC by decreasing the flow rate to 0.5-1.5 L.min-1.
In new-born piglets, when the brain was kept at the target temperature, rectal
temperature continued to drop until it reached the brain temperature. This decline in rectal
temperature despite a constant brain temperature could be due to the imbalance between
heat production in the rest of the body and the heat lost through cold air-flow in nasal
cavities. It was possible to maintain the brain-body temperature gradient (≈-3°C) during
nasopharyngeal cooling by using colder air temperature and higher flow rate in older
heavier than new-born pigs, i.e. 16 kg versus 2-3 kg and by using heating blanket/sheets
to cover the whole body (Appendix B). The nasopharyngeal air cooling method can be
easily implemented in hospitals and even on ambulances to selectively cool down the
brain to ameliorate brain damage from hypoxia-ischemia in newborns and traumatic brain
injuries in children and adults and in resuscitated cardiac arrest patients and in stroke
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patients. This study was the first step in developing a reliable, safe and efficient cooling
device for future clinical trials on the neuroprotective effects of mild hypothermia and
will be of benefit to different patient populations.

(ii) Whole-Body Cooling with Mechanical Ventilation of Cold
Air via the Respiratory Tract
Based on considerations of their anatomical architecture and intimate contact with
the entire cardiac output, lungs and the pulmonary circulation may act as in-vivo
exchanger by transferring heat from the pulmonary blood to cold air introduced by
ventilation into alveolar spaces in the lungs and then to the environment. Experimental
results described in Appendix A, show that the brain temperature fell from 38.3 ± 0.3°C
to 36.5 ± 0.6°C during three hours of ‘pulmonary’ cooling which corresponded to a mean
cooling rate of 0.6 ± 0.1°C/h. The relatively small cooling rate observed in this study
could be explained by a combination of reasons. Using a single endotracheal tube for both
inspiration and expiration allows rapid warming of the incoming cold air by
countercurrent heat exchange between inspired and expired gas in the endotracheal tube
and upper airways before reaching the alveoli. The heat exchange between inspiratory
and expiratory gas is a powerful mechanism for thermal isolation of alveolar gas and
normally prevents penetration of cold environmental gas beyond 10-15 cm in the upper
airway.1 Another drawback of pulmonary cooling is adverse side effects associated with
whole body cooling as discussed in “Introduction”.

5.2 Monitoring of Brain Temperature by TR-NIRS
Technique
Wide clinical adaptation of mild hypothermia has been hampered by the lack of a
reliable noninvasive method for monitoring local brain temperature to adjust cooling and
rewarming rate. The commonly used core (rectal) temperature is a poor substitute as it
has been shown to not always reflect brain temperature. Since the brain is composed of
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80-90% water and its absorption of near infrared (NIR) light depends on temperature, the
goal of this work was to develop an optical technique for measuring brain temperature by
exploiting the temperature-dependency of water absorption of NIR light.
Specifically, we developed a method based on TR-NIRS to measure temperature
continuously and noninvasively in tissue-mimicking phantoms (in-vitro) and deep brain
tissue (in-vivo) during heating and cooling. For deep brain tissue temperature monitoring,
experiments were conducted on newborn piglets wherein hypothermia was induced by
packing the whole body in ice packs. Brain temperature was concomitantly measured by
TR-NIRS and by an invasive thermometer. Our proposed TR-NIRS method was able to
measure the temperature of tissue-mimicking phantoms and brain tissues with a
correlation of 0.82 and 0.66 to temperature measured with a thermometer, respectively.
The mean difference between the TR-NIRS and thermometer measurements was 0.15 ±
1.1°C for the in-vitro experiments and 0.5 ± 1.6°C for the in-vivo measurements.

5.3 Coupling of Cerebral Blood Flow and Oxygen
Consumption During HT Under Different
Anaesthetics Measured with a TR-NIRS Technique
As discussed in detail in the introduction chapter of this thesis, neuroprotective
effects of HT is partly due to suppression of cerebral metabolism to match the demand of
oxygen with supply so as to maintain the tissue oxygenation status. In the brain, tissue
oxidation status is reflected by the OEF, which is the ratio of CMRO2 to CBF, as this is
tightly controlled to be around 33% under normal conditions. Imbalance in supply and
demand of oxygen, or oxidative stress, whatever the cause will lead to an increase in
OEF. The focus of our work in this project was, therefore, two-fold: first, to evaluate the
ability of the TR-NIR technique to measure CMRO2 and CBF in piglet brain and second,
to investigate the effects of hypothermia and different anesthetic regimes on OEF in
normal piglets.
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A bolus-tracking method, using ICG as a flow tracer with TR-NIR technique, was
used to measure CBF and CMRO2 in newborn piglets in which brain temperature was
lowered from ≈38°C to ~33°C under three anesthetic regimes, i.e., Isoflurane,
Propofol/Nitrous-Oxide (N2O) and Propofol/Xenon (Xe)40-50%. Results demonstrate that
TR-NIR can measure CBF with reasonable accuracy as compared to the reference CT
Perfusion method2 and is sensitive to flow changes induced by either hypothermia or
anesthetic drugs. There was a good agreement between CBF obtained with the two
methods (R2=0.84, ∆(mean difference between CT Perfusion and TR-NIR)=5.84 ml. min1

.100 g-1), demonstrating the ability of the TR-NIR technique to non-invasively measure

absolute CBF in-vivo during HT. The TR-NIR technique reveals that CBF decreases from
54.3 ± 5.4 ml. min-1.100 g-1, at normothermia (brain temperature ~38°C), to 33.8 ± 0.9
ml. min-1.100 g-1 at a brain temperature of ~32°C during HT treatment under isoflurane
anesthesia. Both CBF and CMRO2 were affected by changing the anesthetic regime.
However, the ratio of CMRO2 to CBF (or OEF) remained unchanged at around 33%
which indicates, as expected, different anesthetics over the mild hypothermia temperature
range does not cause oxidative stress in the brain such that the tight coupling of flow and
metabolism is maintained in the resulting normoxia condition.

5.4 Future Work
(i) Advances in the Selective Brain Cooling Approach
Our in-vivo experimental studies have demonstrated the feasibility of selective
brain cooling using the nasopharyngeal air cooling approach. One important aspect which
was not tested in our experiments is controlling the rewarming rate. As discussed in detail
in the introduction chapter, rewarming is a critical phase of therapeutic hypothermia in
that too fast a rewarming rate will lead to oxidative stress and subsequent brain damage.
Thus, understanding, predicting, and managing possible adverse effects of rewarming is
important for guaranteeing hypothermia efficacy. To better control cooling and
rewarming rates, further development required include developing and testing a prototype
device with a computer-controlled feedback system to automatically adjust settings of
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cold air temperature and flow rate to arrive at desired brain temperature or cooling or
rewarming rates.
Before the nasopharyngeal air cooling method can be used in clinical trials, more
experimental studies are necessary to evaluate the efficiency of the device and
reproducibility of the results in large animal models of normal and injured brain. In
addition, patient safety is a critical aspect of the evaluation. Although it is unlikely that air
at subzero temperature and high flow rate will induce freezing damage to the mucosa and
embedded blood vessels and nerves of the nasal cavity, histological analyses of the
excised tissue from the nasal cavities of animals studied should be performed to assess for
tissue damages.

(ii) Improvement in Temperature Prediction
Compared to discrete-wavelength approaches, access to a continuous NIR
absorption spectrum offers two important advantages i.e., better chromophore
identification and improved concentration quantification. These features are particularly
useful when chromphore spectra are used to predict deep tissue temperature. To obtain
chromophore spectra, broadband optical spectroscopy will be made available within the
existing TR system through the incorporation of a broadband spectrometer. The intensity
spectra from broad band spectroscopy will be calibrated by the scattering and absorption
coefficients measured by time-resolved (TR) method at a number of wavelengths to
provide an absolute scattering and an absolute absorption spectrum of the tissue from
600-1050nm. From the absorption spectrum, the absolute chromophore concentrations
along with water spectral information within the tissue can be determined. Furthermore,
as a water molecule hydrogen bonds to other molecules its absorption changes by redshifting and broadening. As a result, a bound water correction should be used to account
for the shifting and broadening of the water spectra to improve temperature prediction 3, 4.
The major challenge in adapting this technique to adult patients is the significant
signal contamination from superficial tissues. This is not a concern in neonatal
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applications, where the scalp and skull is negligible and it is reasonable to assume that all
the collected light has traveled through brain tissue. However, in the adult subjects, the
scalp, skull, and cerebral spinal fluid surrounding the brain can contribute significantly to
absorption. In this case, it becomes very difficult to measure absolute concentrations of
cerebral chromophores. It has previously been demonstrated that the depth sensitivity of
the NIR signal is proportional to the distance separating emitter and detector.5 This multidistance, or depth-resolved approach allows the separation of information into superficial
and deep components on the basis that light penetration increases with source-detector
distance. Consequently, by collecting information at multiple distances simultaneously, it
is possible to separate out information in terms of tissue layers, using an optical
reconstruction approach.6

(iii) Investigate the Effects of HT/Xe Administration on FlowMetabolism Coupling in a Hypoxic-Ischemic Model Using
TR-NIR
We have already shown that under normoxic conditions, mild hypothermia with
different anesthetics preserved flow-metabolism coupling resulting in constant oxygen
extraction fraction at ~33%. As the next step, it is necessary to investigate using piglet
hypoxia-ischemia models whether under oxidative stress, the neuroprotective effect of
mild hypothermia will preserve tight coupling of flow and metabolism as observed in
normoxia. Since TR-NIR is safe and measurements can be obtained at the bedside in only
a few minutes, it is believed that this technique could assist in monitoring of
neuroprotection in the neonatal intensive care unit during combination therapies of
hypothermia and Xe administration.

5.5 Conclusion
In summary, the significant findings in this thesis include:
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1) Nasopharyngeal air cooling by spraying humidified and cold air into nasal cavities
is an effective, safe and simple method to selectively reduce and maintain brain
temperature, with no major disturbances in physiological variables or adverse
effects.
2) The developed TR-NIRS temperature measurement technique is able to measure
brain temperature non-invasively in neonatal pig to an accuracy of 0.5 ± 1.6°C.
3) Both cerebral metabolic activity (CMRO2) and CBF can be measured by TRNIRS. Moreover, mild hypothermia under different anesthetics preserves the
coupling between CBF and CMRO2 in normoxia.
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Appendix A
Brain Cooling With Ventilation of Cold Air Over
Respiratory Tract: Experimental and Numerical
study
Appendix A is adapted from the work entitled “Brain Cooling With Ventilation of Cold
Air Over Respiratory Tract: an Experimental and Numerical study”, by M Fazel
Bakhsheshi, EE Stewart, H Vafadar, L Keenliside and TY Lee, submitted to the Journal
of International Communications in Heat and Mass Transfer. The focus of this paper is to
investigate the effects of cold gas (O2-Air) introduced through an endotracheal tube on
brain temperature.

A.

Introduction
From the neonatal asphyxia studies, only one in six children benefit from this

treatment1, and the rate of death and disabilities remains high in these cooled infants.1
Xenon (Xe) is a rare noble gas with anesthetic properties, also showing a great promise as
a neuroprotectant.2-5 Recent investigation showed that inhalation of Xe had an additive
neuroprotective effect with HT; shown to increase neuroprotection from ~35%
(hypothermia only) to ~70% when hypothermia was combined with 50% inhaled Xe gas.6
Based on anatomical features and effectiveness of pulmonary architecture and its
intimate contact with the entire cardiac output, lung and pulmonary circulation may act as
in vivo heat exchanger, such that heat can move from the blood to alveolar space and then
to the environment.7-10 In the present study, we evaluate the efficiency of pulmonary and
brain cooling with and without xenon administration over respiratory tract. These data are
difficult to acquire in clinical setting, as the cost and scarcity of Xe, as well as accuracy of
invasive measurements of brain tissue temperature cannot be easily justified. Therefore,
we took advantage of advances in the numerical modeling of heat and water vapor
transport in tissues and used computational approach to predict temperature distribution
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in the brain during pulmonary cooling using two different gas mixtures, i.e., O2-Air (1:2)
and O2-Xe (1:2). In addition, we have investigated the effect of some physiological
parameters across respiratory tract through numerical simulation. Following numerical
simulations, we examined the theoretical predictions in anesthetized piglets to investigate
the effects of cold gas (O2-Air) introduced through an endotracheal tube on brain
temperature, and we concurrently measured physiological parameters during whole
experiments.

A.1 Materials and Methods
A.1.1 Theoretical Model
Analysis of heat and water transport process in the respiratory tract is a difficult
task because the flow patterns inside this area are rather complex. For simplicity, the
airway can be idealized as a long, right circular cylinder structure11, which simplifies the
theoretical analysis (Figure A.1). Based on the well-known Pennes bioheat transfer
equation12, balance of the energy in the tissue between heat conduction through cellular
tissue portion, heat convection by flow of blood and the heat production due to cellular
metabolism results as follows:

C

T
   kT   b cb Tb  T   Q
t

(A.1)

where ρ(kg.m-3), C(J.kg-1.ºC-1), and k(w.m-1.ºC-1) are the density, specific heat, and
thermal conductivity of tissue, T(ºC) is the local tissue temperature, and t(s) is the time,
ωb(kg.m-3.s-1) is the volumetric blood perfusion rate, Cb(J.kg-1.ºC-1) is the specific heat of
blood, Tb(ºC) is the supplying arterial blood temperature and Q(W.m-3) is the metabolic
heat generation rate.
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Figure A.1. Schematic diagram of the airway model.

At the mucous-air interface (r = a), the boundary condition for the heat transfer is
generally composed of two parts, i.e., convection and evaporation. At the entrance of the
nasal cavity (x = 0), the continuity of heat flux is imposed as a convective boundary
condition and also at both deep tissue (r = b) and the end of human respiratory tract (x =
L) heat flux is assumed to approach zero. The boundary conditions can be written as
follows11:
T
 h T  TA   0.001HM m  Pm*   Pf* 
r
T
0
r
T
k
 h T  Tin 
x
T
0
x

k

r=a

(A.2)

r=b

(A.3)

x=0

(A.4)

x=L

(A.5)

where Tin(ºC) is the breathing air temperature, h' is the apparent heat convection
coefficient between the tissue and the breathing air , h(W.m-2.ºC-1) is the heat convection
coefficient between the mucosal surface and the flowing airstream for each air stream,
i.e., O2-Air and O2-Xe13,

14

.  is the relative humidity of flowing air from ventilator;
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H(J.kg-1) is the latent heat of water vapor; Mm (kg.s-1.m-2.Pa-1) is water penetrative
coefficient in mucosal surface; P*f(Pa) is the saturated vapor pressure at breathing air
temperature and p*m(Pa) is the saturated vapor pressure at tissue temperature which can
be calculated as following15:

ln( P* ) 

c1
 c2  c3T  c4T 2  c5T 3  c6ln T 
T

(A.6)

where ln is the natural logarithm. In the respiratory tract, the energy balance equation for
the air can be defined as11:
HM m  Pt*   Pa*  
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where CA(J.kg-1.ºC-1) and A(kg.m-3) are the specific heat and density of the air at each
condition; S(m2) and A(m2) are the local airway cross-section and perimeter; u(m/s) is the
mean longitudinal air velocity. The air temperature gradients in the axial direction are
usually much smaller than that in the radial direction. Correspondingly, the axial
conduction is neglected here for simplicity. During the inspiration and expiratory phases
of the breathing cycle, the axial inlet (x = 0) boundary condition is considered as the
ventilator air temperature (TA = Tin) and the heat flux is assumed to approach zero (

TA x  0 ) at the end of the human respiratory tract (x = L). The energy balance for the
blood and tissue is defined by conduction in the tissue and convection in the blood as
follows:

k

Tm  x, a, t   Tm  x, b, t 
(b  a)

 hbt Tm  x, b, t   Tb  x, t  

(A.8)

Where hbt is heat convection coefficient between blood and tissue, a(m) is the radius of
respiratory tract, b(m) is the external radius of calculation domain and k(W.m-1.ºC-1) is
the thermal conductivity of tissue. Numerical simulation was applied to solve above
equations and calculate the thermal impact of inhaled cold air to the mucous membrane
and blood temperature which therefore used to predict the brain tissue temperature using
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the mathematical model of temperature distribution in Equation (A.1) for the brain tissue
parameters. For the thermal boundary condition, the heat flux is assumed to approach
zero at the outer boundaries of the brain tissue.16 The initial condition is a steady-state
temperature uniform distribution at thermoneutral conditions (T = 38.5°C). The typical
values for tissue and air properties for following numerical calculation are presented in
Table A.1.12, 15, 17, 18
Table A.1: Base set of parameters used in heat sink thermal model.12, 15, 17, 18
Symbol
Unit
Value
-3
ρB,m
(kg.m )
1030
Cb
(J.kg-1.ºC-1)
3643
Qm
(W.m-3)
420
QB
(W.m-3)
5370
Mm
(kg.s-1.m-2.pa-1)
1.3 e-6
hbt
(W.m-2.ºC-1)
10000
h´
(W.m-2.ºC-1)
50
H
(J.kg-1)
2431
a
(m)
0.005
b
(m)
0.025
L
(m)
0.3
u
(m.s-1)
0.68
Tin
(ºc)
5
k
(W.m-1.ºC-1)
0.5
A
(m2)
7.85 e-5
S
(m)
0.032
(kg.m-3.s-1),
3-11,
ωb
(ml.100g-1.min-1)
(15-66)
c1, c2, c3,
-5800, 1.4, -0.05,
c4, c5, c6
4.2 e-5, 7.8 e-5, 6.5
0.3


A.1.2 Animals Preparation and Experimental Procedure
Experiments were conducted on nine piglets. All animal experiments were
approved by the Animal Use Subcommittee of the Canadian Council on Animal Care at
the University of Western Ontario. Newborn Duroc cross piglets were obtained from a
local supplier on the morning of the experiment. Piglets were anesthetized with 1-2%
isoflurane (3-4% during preparatory surgery). A tracheotomy was performed and the
piglet was ventilated with a volume-controlled mechanical ventilator to deliver O2 and
medical air mixture with the following variable values: tidal volume 10 mL/kg, frequency
35-45/min and fractional concentration of inspired O2 (FIO2) 1.0. A femoral artery was
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catheterized to monitor HR and MAP and to intermittently collect arterial blood samples
for gas (paCO2, paO2), pH and glucose analysis. Arterial CO2 tension (paCO2) was
monitored throughout the experiment, either directly by blood gas measurements or by
the end-tidal CO2 tension, and maintained at normocapnia between 37-42 mmHg by
adjusting the breathing rate and volume. Arterial oxygen tension (paO2) was maintained at
a level between 90-130 mmHg by adjusting the ratio of O2 to medical air. Blood glucose
was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of 25%
glucose solution was administered intravenously. After surgery, piglets were maintained
on 1-2% isoflurane at normothermia using heated water blanket to maintain rectal
temperature between 37.5-38.5°C. Piglets were randomized in two groups, control group
in which piglets were just covered with blankets to maintain their body temperature
(Group I, n = 4); and pulmonary cooling group in which heat loss through respiratory
airways occur by cooling of inhalation gases (Tin ≈ -3 ± 3°C) right before going to trachea
via shortened endotracheal tube while their body were covered with blankets during
whole experiments (Group II, n = 5). Rectal temperature was recorded from a rectal probe
inserted to 3-4 cm from the anal margin. Deep brain temperature was also measured
continuously with a thermocouple probe. A hole was made in the skull with a Dremel
tool. The needle thermocouple probe was inserted laterally through the skull into the brain
to a depth of 2 cm vertical from the brain surface and 0.5 cm posterior to the bregma.
Each experiment was completed within 5 hours. After the last measurement, the animals
were sacrificed using potassium chloride IV (1-2 ml/kg) while on 5% inhaled isoflurane.
The ambient temperature of the animal libratory was maintained relatively constant at 22
± 0.5°C.

A.1.3 Pulmonary Cooling Approach
Cold inspired air was generated by circulating inhalation air, delivered from
ventilator, through coiled heat exchanger immersed completely in water bath before
delivering to piglet, as shown in Figure A.2. Before starting the cooling process, the
cooling unit which control the temperature of water bath was set to -20°C with a
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temperature stability of ±0.05°C over 30-45 min; settings were kept the same during the
entire experiment. The inhaled temperature (-3 ± 3°C) was monitored between the air
cooling system and endotracheal tube. During expiration, air leaving the lungs at body
temperature is cooled as it passes along the respiratory tract by mixing with cold inspired
air.

Figure A.2. Schematic representation of the cooling circuit used for pulmonary cooling.

A.1.4 Statistical Analysis
SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses.
Normality of the distribution of the measurements was verified using KolmogorovSmirnov (KS) test. Comparisons between time-based measurements within groups were
performed by Friedman test. Man Whitney U test was used to determine statistical
differences of cooling rates as a function of treatment group. Statistical significance was
based on p-value < 0.05. All data are presented as mean ± SD unless otherwise noteds

A.2 Results
Animal experiments were conducted on nine piglets (five females and four males),
with an average age of 4.5 ± 1.5 days old and an average weight of 3.7 ± 1.2kg. Table A.2
present a summary for the averaged physiologic parameters of the piglets (MAP, HR and
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paCO2) in each group. The results presented in Table A.2 demonstrate that HR and MAP
dropped slowly through nasopharyngeal cooling approach. The results of arterial blood
gas analysis were corrected for temperature. No significant changes were found between
two groups with respect to HR, MAP, paO2, paCO2, tHb, or pH.
Table A.2: Physiological parameters measured at different groups.
Baseline
Cooling
Variable
1-60min
0.5hr
1.5hr
MAP
Group I
55 ± 7
52 ± 6
54± 7
(mmHg)
Group II
55 ± 10
56 ± 10
52 ± 7
Group I
162 ± 16
163 ± 15
162 ± 16
HR (bpm)
Group II
152 ± 38
156 ± 51
155 ± 40
Group I
39 ± 3
40 ± 3
39 ± 3
paCO2
(mmHg)
Group II
42 ± 3
41 ± 2
37 ± 2
paO2
Group I
131 ± 44
133 ± 32
125 ± 30
(mmHg)
Group II
127 ± 40
132 ± 35
128 ± 30

3hr
53± 5
47± 7
157 ± 18
141 ± 31
39 ± 2
41 ± 2
142 ± 24
127 ± 34

Figure A.3 (a) displays the maximum absolute cooling rates as monitored in the
brain obtained from groups I and II as well as theoretical models for O2-air (1:2) and O2Xe(1:2) conditions. In animal experiments, mean brain cooling rate was significantly
greater (p<0.05) in pulmonary group i.e., (Group II) as compared with control group
(Group I). In the control group, both rectal and brain temperatures did not drop more than
0.3 ± 0.1°C. Figure A.3-b displays the measurements of the brain temperature as a
function of time during ventilation of cold O2-air (1:2) in both experimental and
theoretical models. In animal experiments, following the baseline (38.3 ± 0.3°C), the
brain temperature reached to 36.5 ± 0.6°C which corresponded to a mean cooling rate of
0.6 ± 0.1°C/h, respectively. Average temperature difference between rectal and brain was
0.5 ± 0.1°C during whole animal experiments. Numerical simulations for two different air
conditions (i.e., O2-Air and O2-Xe) during pulmonary cooling show that brain
temperature drop to 35.1 ± 0.4°C and 35.7 ± 0.5°C which corresponded to a mean cooling
rate of 0.98 ± 0.35°C/h and 0.8 ± 0.3°C/h, respectively (Figure A.3-a). Average
temperature difference between two air streams was 0.2±0.1°C over three hour's
simulation. Numerical simulations show no significant differences between two different
inhaled conditions with respect of cooling rate.
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(a)

(b)

Figure A.3. (a) Maximum cooling rate for brain as a function of groups and theoretical predictions;
(b) Brain temperature measurements over time for experimental and theoretical model.

In addition, numerical calculations were performed to investigate the effect of
some physiological parameters such as blood perfusion, thermal conductivity, metabolic
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rate and air velocity across respiratory tract as displayed in Figure A.5 (a-d), respectively.
According to the numerical results, decreasing the perfusion, metabolic rate and
increasing the thermal conductivity and flowing air velocity is accelerated cooling in
respiratory tract and brain tissue accordingly. For simplicity, all tests for respiratory tract
in order to investigate the effect of different parameters on temperature profiles have been
carried out for only an hour.

(a)

(b)
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(c)
Figure A.4. Effects of (a) blood perfusion level; (b) air velocity, and (c) metabolic rate across
respiratory tract response on blood temperature. Calculation were carried out with thermal
conductivity k = 0.5 w.m-1.ºC-1, flowing air temperature Tin = 5ºC, metabolic rate Qm = 420 w.m-3,
local mean longitudinal air velocity V = 30 cm3.s-1 and blood perfusion rate ωb = 50 ml. min -1.100 g 1
as a default values for each simulations.

A.3 Discussions
There are different methods of cooling which utilize different physiological
mechanisms of convective and conductive heat loss. Since the entire cardiac output
passes through the pulmonary capillary network and the heat of the body can be
transferred to the environment via the vast alveolar surface, the lung can serve as a core
heat exchanger. As a consequence of conduction, convection, and water evaporation, heat
is lost from the trachea and respiratory tract, and the temperature of these surfaces falls
below body temperature and this eventually cooled down the whole body.7-10 Forman et
al. and Shaffer et al. have demonstrated the feasibility of liquid ventilation to induce
hypothermia.8, 9 In their methods, liquid ventilation was used to induce hypothermia with
the cooling rate of 4.8-8.4°C/h, in which perfluorocarbon (PFC) liquids of 20-30°C were
tidally exchanged from the lung by an extracorporeal circuit. The problem with their
method is associated with the safety profile of its coolant. PFCs are powerful greenhouse
gases and deplete the ozone layer and are listed as toxic substances under the Canadian
Environmental Protection Act (CEPA).19 Another safety concern is the risk of coolant
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aspiration which might cause lung damage over prolonged periods since neural protection
therapy may involve mild hypothermia being maintained for period of 72 hours.20
Insufflations of cold gas have also been studied; however, sufficient cooling rates can
only be achieved with very cold inhalation.7, 10
Our study shows that the brain temperature of those animals breathing cold O2-Air
fell to 36.5 ± 0.6°C in three hours without significant hemodynamic deterioration which
corresponded to a mean cooling rate of 0.6 ± 0.1°C/h. Relatively small cooling rate in this
study could be explained by combination of different reasons. Eemploying single
endotracheal tube for both of inspiratory and expiratory gas increases the efficiency of the
heating as cold air warmed rapidly by countercurrent heat exchange between inspired and
expired gas in the endotracheal tube and upper airways before reaching to the alveoli. The
heat exchange in the upper airway is a powerful mechanism for thermal insulation of
alveolar gas and normally prevents penetration of cold environmental gas beyond 10-15
cm.21 The potential for increasing evaporative heat loss from the respiratory tract is also
limited by the detrimental effects of prolonged ventilation with dry gas and should not be
used clinically used to lower temperature.22
In the present study, a computational program was written with MATLAB to
calculate and analyze the transient temperature distribution across the respiratory tract
and within the brain using control-volume finite-difference method.23 We also show how
changes of different parameters can affect the temperature profiles in the respiratory tract.
The heat exchange across the respiratory tract depends on the airflow rate, the
temperature of expiratory and the inspiratory gas, and its thermal properties. Figure A.5
(a) shows the temperature change for three different blood perfusion rates. It can be seen
that larger blood perfusion tends to prevent the biological tissues from cooling. This result
can explain the fact that newborns, whose blood perfusion is generally lower, are easier to
be cooled than adults. As Figure A.5 (b) displays, higher air velocity yields greater
cooling effects. Figure A.5(c) also shows the temperature responses with different
metabolic rates. Clearly, the cooling rate can be increased with lower metabolic rate.
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They are several limitations in our numerical study that should be pointed out. For
example, more complex geometrical and physiological parameters of the respiratory
system may be incorporated for a more comprehensive estimation of brain tissue
temperature during pulmonary cooling. In this study, some brain and respiratory thermal
parameters, including air velocity and the metabolic rate are assumed to be constant in the
tissue due to relatively small change in temperature. However, It has been shown that
reducing brain tissue temperature from 37 to 34ºC reduces the metabolic rate by about
25%. Piglets were studied because they are commonly used animal model of newborn
human neurology.
The effect of different thermal properties of respiratory gas on brain cooling was
examined using two different air streams with theoretical model. Although the thermal
conductivity and specific heat capacity of air are 5-6 times more than Xe, but the heat
exchange via the respiratory tract and brain cooling rate was still very smile by
substituting Air with Xe. The thermal properties of O2-Air and O2-Xe are compared in
Table A.3.24 Numerical simulations show no significant differences between two different
inhaled conditions with respect of cooling rate with average temperature difference of 0.2
± 0.1°C over three hours simulation. Neuroprotective effect of hypothermia has been
linked to how rapidly cooling is initiated, how quickly the brain is cooled, the etiology of
injury and the extent of tissue that reaches the therapeutic hypothermic zone.25,

26

Therefore, the results of this work suggest that simultaneous administration of HT and Xe
with pulmonary cooling technique is inefficient to induced rapid cooling.
Table A.3: Comparison of some physical properties of O2-Air and O2Xe at normal atmospheric pressure.24
O2-Air(1:2)
O2-Xe(1:2)
Density
(kg.m-3)
1.5
4.014
Specific Heat (J.kg-1.ºC-1)
900
246
Thermal
(W.m-1.ºC-1)
0.021
0.010
Conductivity

136

A.4 References
1.

Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM,
Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head
cooling with mild systemic hypothermia after neonatal encephalopathy:
Multicentre randomised trial. Lancet. 2005;365:663-670

2.

Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic
properties of the 'inert' gas, xenon. Br J Anaesth. 2002;89:739-746

3.

Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H,
Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide
neuroprotection from neonatal asphyxia. Ann Neurol. 2005;58:182-193

4.

Dingley J, Hobbs C, Ferguson J, Stone J, Thoresen M. Xenon/hypothermia
neuroprotection regimes in spontaneously breathing neonatal rats after hypoxicischemic insult: The respiratory and sedative effects. Anesth Analg. 2008;106:916923, table of contents

5.

Martin JL, Ma D, Hossain M, Xu J, Sanders RD, Franks NP, Maze M.
Asynchronous administration of xenon and hypothermia significantly reduces
brain infarction in the neonatal rat. Br J Anaesth. 2007;98:236-240

6.

Thoresen M, Hobbs CE, Wood T, Chakkarapani E, Dingley J. Cooling combined
with immediate or delayed xenon inhalation provides equivalent long-term
neuroprotection after neonatal hypoxia-ischemia. J Cereb Blood Flow Metab.
2009;29:707-714

7.

Zikria BA, Ferrer JM, Malm JR. Pulmonary hypothermia in dogs. J Appl Physiol.
1968;24:707-710

8.

Shaffer TH, Forman DL, Wolfson MR. Physiological effects of ventilation with
liquid fluorocarbon at controlled temperatures. Undersea Biomed Res.
1984;11:287-298

9.

Forman DL, Bhutani VK, Tran N, Shaffer TH. A new approach to induced
hypothermia. J Surg Res. 1986;40:36-42

10.

Harrison MR, Hysing ES, Bo G. Control of body temperature: Use of the
respiratory tract as a heat exchanger. J Pediatr Surg. 1977;12:821-828

11.

Hanna LM, Scherer PW. A theoretical model of localized heat and water vapor
transport in the human respiratory tract. J Biomech Eng. 1986;108:19-27

137
12.

Duck FA. Physiological properties of tissues: A comprehensive reference book.
San Diego Academic; 1990.

13.

Hanna LM, Scherer PW. Measurement of local mass transfer coefficients in a cast
model of the human upper respiratory tract. J Biomech Eng. 1986;108:12-18

14.

Nuckols ML. Heat and water transfer in the human respiratory system at
hyperbaric conditions. 1981;Ph. D. Dissertation

15.

American Society of Heating Refrigerating and Air-Conditioning Engineers.
Ashrae handbook – fundamentals. 2009.

16.

Xu X, Tikuisis P, Giesbrecht G. A mathematical model for human brain cooling
during cold-water near-drowning. J Appl Physiol. 1999;86:265-272

17.

Liu J. Bioheat transfer. Beijing: Science Press; 1997.

18.

Holmes
KR.
Thermal
"http://users.Ece.Utexas.Edu/~valvano/research/thermal.Pdf".2013

19.

Chemicals Management Division of Environment Canada. List of toxic substances
managed under cepa (schedule 1), available at: Http://www.Ec.Gc.Ca/toxiquestoxics/default.Asp?Lang=en&n=98e80cc6-1&xml=aa329670-c3c7-4ad5-a7ab5fd8a05439f1. 2005;2013

20.

Azzopardi D, Strohm B, Edwards AD, Halliday H, Juszczak E, Levene M,
Thoresen M, Whitelaw A, Brocklehurst P, Steering G, participants TCR.
Treatment of asphyxiated newborns with moderate hypothermia in routine clinical
practice: How cooling is managed in the uk outside a clinical trial. Arch Dis Child
Fetal Neonatal Ed. 2009;94:F260-264

21.

Webb P, Bennett P, Elliot DM. The physiology and medicine of diving. London:
Bellaire Tindall; 1974.

22.

Marfatia S, Donahoe PK, Hendren WH. Effect of dry and humidified gases on the
respiratory epithelium in rabbits. J Pediatr Surg. 1975;10:583-592

23.

Recktenwald G. The control-volume finite-difference approximation to the
diffusion equation. 2003

24.

Katz I, Caillibotte G, Martin AR, Arpentinier P. Property value estimation for
inhaled therapeutic binary gas mixtures: He, xe, n2o, and n2 with o2. Med Gas
Res. 2011;1:28

25.

Behringer W, Prueckner S, Safar P, Radovsky A, Kentner R, Stezoski SW,
Henchir J, Tisherman SA. Rapid induction of mild cerebral hypothermia by cold

properties

138
aortic flush achieves normal recovery in a dog outcome model with 20-minute
exsanguination cardiac arrest. Acad Emerg Med. 2000;7:1341-1348
26.

Kuboyama K, Safar P, Radovsky A, Tisherman SA, Stezoski SW, Alexander H.
Delay in cooling negates the beneficial effect of mild resuscitative cerebral
hypothermia after cardiac arrest in dogs: A prospective, randomized study. Crit
Care Med. 1993;21:1348-1358

139

Appendix B
Comparison of Selective Brain Cooling in Juvenile
and Newborn Piglets Using a Nasopharyngeal
Method
B.1 Materials and Methods
Animals were anesthetized with 1-2% isoflurane. A tracheotomy was performed
and the animal was ventilated with a volume-controlled mechanical ventilator to deliver
Oxygen (O2) and medical air mixture. A femoral artery was catheterized to monitor HR
and MAP and to intermittently collect arterial blood samples for gas (paCO2, paO2), pH
and glucose analysis. Animals were randomized into the different groups:
I. control group in which whole body of piglet was covered with blankets, (n=3);
II. nasopharyngeal cooling group in which hypothermia was induced by directing
humidified and cooled medical air (≈-8°C) at the flow rate of 14-15 Liter.min-1 into the
nasal cavities via catheters while core body temperature was maintained within 35.536.5°C using heating blanket and hot water gloves by iteratively turning heating blanket
"on" and "off" at;
II-a. New-born piglets with an average age 1-2 days old and an average weight of ≈12kg, (n=3) and;
II-b. Juvenile pigs with an average age of 3 weeks old and an average weight of
≈16kg, (n=2);
Rectal temperature was recorded from a rectal probe inserted to 3-4 cm from the anal
margin. Brain temperature measured far away from nasal cavities (7-8cm) to make sure to
achieve whole brain cooling at depth of 2 cm vertical from the brain surface and 1.5 cm
posterior to the bregma.
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B.2 Results
Table B.1 presents a summary for the averaged physiologic parameters for each
group related to Figure B.1. Both the heart rate (HR) and mean arterial blood pressure
(MAP) dropped slowly through nasopharyngeal cooling approach in the new-born piglets,
i.e. group II-a. No significant changes were found in the juvenile pig, i.e. group II-b, with
respect to HR or MAP.
Table B.1. Physiological parameters measured at each group.
Baseline
1-60min
30 min
Control
36 ± 7
34 ± 6
New-born
MAP
46 ± 2
44 ± 2
piglet
Nasal
(mmHg)
Cooling
Juvenile
52 ±3
53 ± 5
pig
163 ±
Control
162 ± 16
15
HR
New-born
145 ±
164 ± 15
(bpm)
piglet
16
Nasal
Cooling
Juvenile
176 ±
181 ± 9
pig
13

Cooling
1 hr
2 hr
36 ± 7
36 ± 7

3 hr
36 ± 7

44 ± 5

37 ± 3

36 ± 5

55 ± 4

50 ± 5

52 ± 4

162 ±
16
133±
19
165±
19

162 ±
16
133±
19
168±
14

162 ±
16
133±
19
170±
17

Figure B.1 displays the maximum absolute cooling rates achieved at each group as
monitored in the brain and core rectal compartment. Results of comparing both groups in
the nasopharyngeal cooling approach using cold and high air-flow rate reveals that it was
possible to increase the brain-rectal temperature gradient in the heavier pigs compared to
new-born piglets, i.e. 16 kg versus 2-3 kg. The rectal cooling rate was approximately onethird of the corresponding brain cooling rate. Effective selective brain cooling was
achieved with a median cooling rate of 2.3 ± 0.3°C/h in the juvenile pigs.
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Figure B.1. Maximum cooling rate for brain as a function of different conditions in Nasal cooling.

Figure B.2(a,b) demonstrate the mean brain and rectal temperature profile as a
function of time in both groups. Results shown in Figure B.2(b) demonstrated that
maximum brain-rectal temperature gradient of -2.5°C reached about 20-30 min after the
initiation of cooling and remained unchanged during the rest of nasopharyngeal cooling.
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(a)

N (b)

Figure B.2. Changes in the brain-rectal temperature over time for intra-nasal cooling method with
setting the air flow rate to 14-15 L.min-1 for (a) piglets with average weight of ≈2-3kg; and (b)
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juvenile pig with average weight of ≈16kg.

B.3 Conclusions
We demonstrated that nasopharyngeal cooling by spraying humidified and cooled
air into nasal cavities is an effective, safe and simple method to selectively reduce and
maintain the brain-body temperature gradient in the heavier pig compare to new-born
ones using heating blanket/sheets.
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